Processing 00000000.tx.1: Mitochondrial Dysfunction Is Involved in Apoptosis Induced by Serum Withdrawal and Fatty Acids in the -Cell Line Ins-1 Isabel Maestre1, Joaqun Jordn1, Soledad Calvo, Juan Antonio Reig, Valentn Cea, Bernat Soria, Marc Prentki and Enrique Roche Instituto de Bioingeniera/Division of Nutrition (I.M., J.A.R., B.S., E.R.), University Miguel Hernndez, San Juan, 03550 Alicante, Spain; 

Phrase: "Mitochondrial Dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "Is"

Phrase: "Involved in Apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1314939:Involved [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "Induced by Serum Withdrawal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205263:Induced [Functional Concept]
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Fatty Acids in the -Cell Line"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0015684:Fatty Acids [Lipid]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "Ins-1 Isabel Maestre1,"

Phrase: "Joaqun Jordn1,"

Phrase: "Soledad Calvo,"

Phrase: "Juan Antonio Reig,"

Phrase: "Valentn Cea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3463961:Cea [Eukaryote]

Phrase: "Bernat Soria,"

Phrase: "Marc Prentki"

Phrase: "and"

Phrase: "Enrique Roche Instituto de Bioingeniera/Division of Nutrition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1293097:Division [Therapeutic or Preventive Procedure]
   744   C2919030:Division [Organization]
   744   C2919031:Division [Activity]

Phrase: "(I.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "J.A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "University Miguel Hernndez,"

Phrase: "San Juan,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1551529:San Juan [Population Group]
   861   C1826357:San [Gene or Genome]

Phrase: "03550 Alicante,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: ";"
Processing 00000000.tx.2: Centro Regional de Investigaciones Biomdicas and Departamento de Ciencias Mdicas (J.J., S.C., V.C.), Facultad de Medicina, University of Castilla-La Mancha, 02071 Albacete, Spain; 

Phrase: "Centro Regional de Investigaciones Biomdicas"

Phrase: "and"

Phrase: "Departamento de Ciencias Mdicas"

Phrase: "(J.J.,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "V.C."

Phrase: ")"

Phrase: ","

Phrase: "Facultad de Medicina,"

Phrase: "University of Castilla-La Mancha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041740:University [Manufactured Object,Organization]

Phrase: "02071 Albacete,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: ";"
Processing 00000000.tx.3: and Molecular Nutrition Unit (M.P.), Departments of Nutrition and Biochemistry, University of Montral and the CR-CHUM, H2L 4M1 Montral, Qubec, Canada Address all correspondence and requests for reprints to: Dr. 

Phrase: "and"

Phrase: "Molecular Nutrition Unit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "("

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Departments of Nutrition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "University of Montral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "the CR-CHUM,"

Phrase: "H2L 4M1 Montral,"

Phrase: "Qubec,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.4: Enrique Roche, Instituto de Bioingeniera, Universidad Miguel Hernndez, Campus de San Juan, 03550 San Juan, Alicante, Spain. 

Phrase: "Enrique Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331965:Roche [Health Care Related Organization]

Phrase: "Instituto de Bioingeniera,"

Phrase: "Universidad Miguel Hernndez,"

Phrase: "Campus de San Juan,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1551529:San Juan [Population Group]
   812   C1826357:San [Gene or Genome]

Phrase: "03550 San Juan,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1551529:San Juan [Population Group]
   827   C1826357:San [Gene or Genome]

Phrase: "Alicante,"

Phrase: "Spain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]
Processing 00000000.tx.5: E-mail: eroche{at}umh.es .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  The potential toxic effects of high extracellular concentrations of fatty acids were tested in (INS-1)-cells cultured in the absence of serum, a condition known to alter cell survival in various systems. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "eroche{at}umh.es .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The potential toxic effects of high extracellular concentrations of fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   780   C0161695:Toxic effect of acids [Injury or Poisoning]
           Toxic effect acids
   754   C0243169:toxic potential [Quantitative Concept]
   738   C0600688:toxic [Injury or Poisoning]
           Toxic effect
   738   C1280500:effects [Qualitative Concept]
   738   C1407029:Toxic [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "in (INS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0150312:In [Quantitative Concept]
   790   C0332285:In [Spatial Concept]
   716   C1414685:INS-1 [Gene or Genome]
   716   C3538717:INS-1 [Gene or Genome]

Phrase: ")-"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in the absence of serum,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0229671:Serum [Body Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1689985:Absence [Anatomical Abnormality]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "a condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "cell survival in various systems."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007620:Cell Survival [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: This may in part mimic the situation in type 1 or 2 diabetes where -cells are already insulted by various stressful conditions, such as cytokines and oxidative stress. 

Phrase: "This"

Phrase: "may in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "mimic"

Phrase: "the situation in type 1"

Phrase: "or"

Phrase: "2 diabetes where -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "already"

Phrase: "insulted by various stressful conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0231297:Stressful [Functional Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "such as cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.7: Serum removal caused, over a 36-h period, oxidative stress and an early impairment of mitochondrial function, as revealed by increased superoxide production and markedly reduced mitochondrial membrane potential, but a lack of cytochrome c and apoptosis-inducing factor release in the cytosol. 

Phrase: "Serum removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015252:Removal [Therapeutic or Preventive Procedure]
   861   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: ","

Phrase: "over a 36-h period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "an early impairment of mitochondrial function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "as"

Phrase: "revealed by increased superoxide production"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033268:production [Occupational Activity]
   760   C0038836:Superoxide [Element, Ion, or Isotope]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0443289:Revealed [Qualitative Concept]

Phrase: "and"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "mitochondrial membrane potential,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "but"

Phrase: "a lack of cytochrome c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "apoptosis-inducing factor release in the cytosol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.8: The fatty acids palmitate and oleate considerably accelerated the apoptosis process in serum-starved cells, as revealed by fluorescence-activated cell sorting analysis, morphological changes, chromatin condensation, DNA laddering, poly(ADP-ribose) polymerase cleavage, cytochrome c and apoptosis-inducing factor release, and increased levels of Bax and cytosolic caspase-2. 

Phrase: "The fatty acids palmitate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030233:palmitate [Lipid]
   827   C3503116:palmitate [Biomedical or Dental Material,Lipid]
   734   C0015684:Fatty Acids [Lipid]

Phrase: "and"

Phrase: "oleate considerably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0133788:oleate [Lipid]
   861   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "the apoptosis process in serum-starved cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0007613:Cell Process [Cell Function]
   757   C0230625:Cell process [Cell Component]
   748   C1184743:Process [Body Part, Organ, or Organ Component]
   748   C1522240:Process [Phenomenon or Process]
   743   C0162638:Apoptotic Process [Cell Function]

Phrase: "as"

Phrase: "revealed by fluorescence-activated cell sorting analysis,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   853   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   778   C0007616:Cell Sorting [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0237886:Sorting [Mental Process]
   748   C0443289:Revealed [Qualitative Concept]
   748   C0700314:sorting [Cell Function]
   748   C0936012:Analysis [Research Activity]
   748   C1269647:Cell [Cell]
   748   C1524024:analysis [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1879547:Activated [Activity]
   748   C1947906:Sorting [Activity]
   748   C1948049:Cell [Spatial Concept]
   714 E C1515877:Activate [Functional Concept]

Phrase: "morphological changes,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   933   C1260954:Morphologic change [Anatomical Abnormality]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0543482:morphological [Spatial Concept]
   827 E C1705241:Change [Quantitative Concept]
   789 E C0332437:Morphology [Qualitative Concept]
   789 E C0700329:Morphology, NOS [Finding]
   789 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "chromatin condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "DNA laddering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336762:laddering [Manufactured Object]

Phrase: "poly(ADP-ribose) polymerase cleavage,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0010813:cleavage [Cell Function]
   804   C0596311:Cleavage [Phenomenon or Process]
   804   C1330957:cleavage [Cell Function]
   771   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
   771   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   717   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "apoptosis-inducing factor release,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]

Phrase: "and"

Phrase: "increased levels of Bax"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "cytosolic caspase-2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1383501:Cytosolic [Cell Component]
Processing 00000000.tx.9: The fatty acids also increased nitric oxide production, apparently independently of inducible nitric oxide synthase induction. 

Phrase: "The fatty acids also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "nitric oxide production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "apparently independently of inducible nitric oxide synthase induction."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
           Inducible NOS
   833   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   833   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0030015:oxide [Inorganic Chemical]
   744   C0205263:Inducible [Functional Concept]
           Induction
   744   C0750541:apparently [Idea or Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.10: Under the same experimental conditions, elevated glucose alone had only a marginal effect on -cell apoptosis. 

Phrase: "Under the same experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "elevated glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "had"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a marginal effect on -cell apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.11: Together the results indicate that elevated concentrations of fatty acids are particularly efficient in accelerating the rate of apoptosis of already stressed (INS-1)-cells displaying altered mitochondrial function, and that the mitochondrial arm of the apoptosis process is involved in -cell lipotoxicity.  

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that elevated concentrations of fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "are"

Phrase: "particularly efficient in accelerating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442799:Efficient [Qualitative Concept]

Phrase: "the rate of apoptosis of already"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "stressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038435:stressed [Finding]

Phrase: "("

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "altered mitochondrial function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "that"

Phrase: "the mitochondrial arm of the apoptosis process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0446516:Arm [Body Location or Region]
   748   C1269078:Arm [Body Part, Organ, or Organ Component]
   748   C1269612:Arm [Body Location or Region]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell lipotoxicity."
Processing 00000000.tx.12: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  REDUCTION OF pancreatic -cell mass has been documented in autoimmune diabetes through the action of several cytokines produced by circulating inflammatory cells. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "REDUCTION OF pancreatic -cell mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "documented in autoimmune diabetes"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0443146:Autoimmune [Pathologic Function]
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]

Phrase: "through the action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "of several cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "produced by circulating inflammatory cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0440752:inflammatory cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0175630:Circulating [Functional Concept]
   760   C0333348:Inflammatory [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.13: These include IL-1, TNF, and interferon- (IFN) which impair cell function, produce DNA damage, and favor cell death in rodent and human -cells (1). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "IL-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "TNF,"

Phrase: "and"

Phrase: "interferon- (IFN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "impair"

Phrase: "cell function,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "produce"

Phrase: "DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "favor cell death in rodent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "human -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: The mechanism seems to involve nitric oxide (NO) production through the increased expression of the inducible NO synthase (iNOS) gene and disruption of mitochondrial function, leading to the release of apoptogenic factors, such as cytochrome c, which recruits and activates procaspase 9 and additional executioner caspases, and apoptosis-inducing factor (AIF), which induces nuclear chromatin condensation, progressing to apoptosis (2, 3). 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "nitric oxide (NO) production through the increased expression of the inducible NO synthase (iNOS) gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "disruption of mitochondrial function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "leading to the release of apoptogenic factors,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   757   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0332152:Leading [Temporal Concept]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714   C1521761:Factor [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714   C2827422:Factor [Conceptual Entity]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "such as cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "which"

Phrase: "recruits"

Phrase: "and"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "procaspase 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0758917:Pro-Caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "additional executioner caspases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "apoptosis-inducing factor (AIF),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "which"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "nuclear chromatin condensation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0233656:Condensation [Mental or Behavioral Dysfunction]
   827   C0598405:condensation [Natural Phenomenon or Process]
   734   C1325557:Nuclear chromatin [Cell Component]

Phrase: "progressing to apoptosis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0205329:Progressing to [Functional Concept]
           progressing
   790   C0162638:Apoptosis [Cell Function]
   756 E C1272688:progress [Functional Concept]
   756 E C1280477:Progress [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Several lines of evidence also support a possible role for apoptosis in noninsulin-dependent diabetes mellitus. 

Phrase: "Several lines of evidence also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a possible role for apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in noninsulin-dependent diabetes mellitus."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
Processing 00000000.tx.16: In this context, prolonged exposure to an excess of circulating nutrients (glucose or fatty acids) seems to be a key event in the initiation of this death process. 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "prolonged exposure to an excess of circulating nutrients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332157:Exposure to [Clinical Attribute]
           Exposure
   744   C0274281:Exposure, NOS [Injury or Poisoning]
   744   C0439590:Prolonged [Temporal Concept]

Phrase: "(glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a key event in the initiation of this death process."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0441471:Event [Event]
Processing 00000000.tx.17: The Zucker diabetic fatty (ZDF) rat model has been extensively studied to decipher the molecular mechanisms implicated in the apoptosis process induced by lipids (4, 5, 6, 7). 

Phrase: "The Zucker diabetic fatty (ZDF) rat model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3161035:Model [Intellectual Product]
   708   C0034719:Zucker rat [Mammal]

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decipher"

Phrase: "the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "implicated in the apoptosis process"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162638:Apoptotic Process [Cell Function]
           Apoptosis
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "induced by lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023779:Lipids [Lipid]
   790   C0205263:Induced [Functional Concept]

Phrase: "(4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.18: Results obtained by different laboratories suggest that lipid accumulation in islet tissue is harmful for -cell function, leading to the development of the so-called toxic effect of lipids, or lipotoxicity. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained by different laboratories"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C1301820:Obtained [Functional Concept]
   770   C1619828:Laboratories [Intellectual Product]
   770   C1705242:Different [Qualitative Concept]
   737 E C1706701:Obtain [Activity]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that lipid accumulation in islet tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333574:Lipid accumulation [Finding]

Phrase: "is"

Phrase: "harmful for -cell function,"

Phrase: "leading to the development of the so-called toxic effect of lipids,"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   753   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   751   C0023176:Lead - toxic effect [Injury or Poisoning]
   736   C0023779:Lipids [Lipid]
   736   C0243107:development [Physiologic Function]
   736   C0332152:Leading [Temporal Concept]
   736   C0678723:Development [Organism Function]
   736   C1280500:Effect [Qualitative Concept]
   736   C1407029:Toxic [Qualitative Concept]
   736   C1522538:Leading [Functional Concept]
   736   C1527148:Development [Functional Concept]
   736   C2348382:Effect [Qualitative Concept]
   703 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   703   C0679006:Call [Mental Process]
   703 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   703   C1947967:Call [Functional Concept]
   703 E C2348269:Lead [Element, Ion, or Isotope]
   703 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "lipotoxicity."
Processing 00000000.tx.19: This is correlated with impaired insulin secretion and changes in the expression of genes involved in the lipogenic and fat oxidation pathways (8, 9). 

Phrase: "This"

Phrase: "is"

Phrase: "correlated with impaired insulin secretion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1707520:Correlated [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "changes in the expression of genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Genes [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "involved in the lipogenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "fat oxidation pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.20: In the ZDF rat model, de novo ceramide formation and increased NO production have been proposed to be involved in final -cell decompensation (4, 5). 

Phrase: "In the ZDF rat model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3161035:Model [Intellectual Product]
   708   C0034719:Zucker rat [Mammal]

Phrase: "de novo ceramide formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1157399:ceramide formation [Molecular Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "increased NO production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in final -cell decompensation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007634:Cell [Cell]
   760   C0205088:Final [Temporal Concept]
   760   C0231187:Decompensation [Finding]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1546485:Final [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: Thus, -cell apoptosis is prevented by pharmacological blockade of serine palmitoyltransferase, which catalyzes the first step in ceramide synthesis, as well as inhibition of acyl-coenzyme A (acyl-CoA) synthetase, which catalyzes the formation of palmitoyl-CoA, the carbon precursor of ceramides. 

Phrase: "Thus, -"

Phrase: "cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "prevented by pharmacological blockade of serine palmitoyltransferase,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0074375:serine palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1817217:serine palmitoyltransferase [Molecular Function]
   748   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   748   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0205464:pharmacological [Functional Concept]
   748   C0332206:Blockade [Functional Concept]
   748   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C3540676:Blockade [Pharmacologic Substance]
   714   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "which"

Phrase: "catalyzes"

Phrase: "the first step in ceramide synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1157399:ceramide synthesis [Molecular Function]
   804   C0220781:synthesis [Biologic Function]
   804   C1883254:Synthesis [Activity]

Phrase: "as well as"

Phrase: "inhibition of acyl-coenzyme A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "(acyl-CoA) synthetase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0050691:Acyl-CoA synthetase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0023689:Synthetase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "catalyzes"

Phrase: "the formation of palmitoyl-CoA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "the carbon precursor of ceramides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.22: This suggests that the rise in ceramides in islets treated with a palmitate/oleate mixture (1:2) might be due to their accelerated de novo synthesis and not from sphingomyelin hydrolysis (7). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the rise in ceramides"

Phrase: "in islets"

Phrase: "treated with a palmitate/oleate mixture"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0030233:palmitate [Lipid]
   753   C0133788:oleate [Lipid]
   753   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   753   C0439962:Mixture [Substance]
   753   C1522326:Treated [Functional Concept]
   753   C3503116:palmitate [Biomedical or Dental Material,Lipid]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "might"

Phrase: "be due to their accelerated de novo synthesis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0678226:Due to [Functional Concept]
           due
   770   C1515568:de novo [Idea or Concept]
   744   C0011198:DE [Geographic Area]
   744   C0017480:DE [Geographic Area]
   744   C0220781:synthesis [Biologic Function]
   744   C0521110:Accelerated [Functional Concept]
   744   C1883254:Synthesis [Activity]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   744   C3541240:DE [Idea or Concept]

Phrase: "and"

Phrase: "not from sphingomyelin hydrolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]
   770   C0037906:Sphingomyelin [Biologically Active Substance,Lipid]
   770   C1518422:Not [Functional Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.23: However, the actions of individual fatty acids (palmitate and oleate alone) were not reported in this study (7). 

Phrase: "However,"

Phrase: "the actions of individual fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441472:actions [Functional Concept]
   719 E C3266814:Action [Activity]

Phrase: "(palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reported in this study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0557651:Study [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2603343:Study [Research Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.24: Accelerated lipolysis, which should avoid intracellular deposition of fat and ceramide synthesis, reduces the apoptotic effect of fatty acids in the -cell. 

Phrase: "Accelerated lipolysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023796:Lipolysis [Organism Function]

Phrase: "which"

Phrase: "should"

Phrase: "avoid"

Phrase: "intracellular deposition of fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "ceramide synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157399:ceramide synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "reduces"

Phrase: "the apoptotic effect of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in the -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.25: Thus, leptin acts by depleting triglyceride deposits in adipose and nonadipose tissues bearing the corresponding receptors. 

Phrase: "Thus,"

Phrase: "leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "acts by depleting triglyceride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "deposits in adipose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0333562:Deposit [Functional Concept]
   718   C0028754:Adiposity [Disease or Syndrome]
   718   C1563743:adiposity [Organism Attribute]

Phrase: "and"

Phrase: "nonadipose tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the corresponding receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.26: Leptin increases the expression of enzymes implicated in fatty acid metabolism and uncoupling protein-2 in rat islets, whereas the hormone reduces the expression of those activities implicated in lipid storage processes (10, 11, 12). 

Phrase: "Leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "implicated in fatty acid metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0596563:Fatty Acid Metabolism [Molecular Function]
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "uncoupling protein-2 in rat islets,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   783   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1425576:ISLET 2 [Gene or Genome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whereas"

Phrase: "the hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "reduces"

Phrase: "the expression of those activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "implicated in lipid storage processes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1159705:lipid storage [Cell Function]
   760   C0023779:Lipid [Lipid]
   760   C0337174:Storage [Spatial Concept]
   760   C1698986:Storage [Functional Concept]
   760   C1753314:storage [Cell Component]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.27: Furthermore, leptin blocked the suppressor effect of fatty acids on the expression level of the antiapoptotic protein Bcl-2 (6). 

Phrase: "Furthermore,"

Phrase: "leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the suppressor effect of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the expression level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of the antiapoptotic protein Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.28: All of these data suggest that the -cell adapts to an elevated circulating concentration of fatty acids through the induction of fatty acid metabolism genes, allowing intracellular lipid detoxification (13). 

Phrase: "All of these data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   770   C3539085:All [Idea or Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "adapts to an elevated circulating concentration of fatty acids"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0015684:Fatty Acids [Lipid]
   742   C0001128:Acids [Chemical]
   742   C0086045:Concentration [Mental Process]
   742   C0175630:Circulating [Functional Concept]
   742   C0205250:Elevated [Qualitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C2937289:adapt [Organic Chemical]
   742   C3163633:Elevated [Qualitative Concept]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "through the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of fatty acid metabolism genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017337:Genes [Gene or Genome]
   756   C0596563:Fatty Acid Metabolism [Molecular Function]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "intracellular lipid detoxification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025516:Detoxification [Organism Function]
   827   C0150543:Detoxification [Therapeutic or Preventive Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.29: To gain insight into the mechanisms by which elevated concentrations of fatty acids cause -cell death, we studied the actions of palmitate and oleate on the (INS-1)-cell apoptosis process. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0233820:Insight [Mental Process]

Phrase: "by which"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "concentrations of fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "cause -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the actions of palmitate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441472:actions [Functional Concept]
   737 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "oleate on the (INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0133788:oleate [Lipid]
   760   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")-"

Phrase: "cell apoptosis process."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0007613:Cell Process [Cell Function]
   913   C0230625:Cell process [Cell Component]
   865   C0162638:Apoptotic Process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.30: In this paper we present evidence that serum deprivation (a widespread working model for apoptosis in several tissues) (14) produces apoptosis in -cells, and that fatty acids considerably accelerate this process. 

Phrase: "In this paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that serum deprivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871712:Deprivation [Qualitative Concept]

Phrase: "("

Phrase: "a widespread working model for apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "in several tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: ")"

Phrase: "(14"

Phrase: ")"

Phrase: "produces"

Phrase: "apoptosis in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that fatty acids considerably"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.31: We propose the participation of the mitochondrial arm of the apoptotic process in the toxic action of fatty acids, as evidenced from disruption of mitochondria function and release of cytochrome c and AIF.  

Phrase: "We"

Phrase: "propose"

Phrase: "the participation of the mitochondrial arm of the apoptotic process"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0679823:Participation [Functional Concept]

Phrase: "in the toxic action"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1256754:toxic action [Hazardous or Poisonous Substance]
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]

Phrase: "of fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "as"

Phrase: "evidenced from disruption of mitochondria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0332120:Evidence of [Functional Concept]
           Evidence
   760   C0026237:Mitochondria [Cell Component]
   760   C0332453:Disruption [Functional Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "release of cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "AIF."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.32: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Cell culture INS-1 cells were grown in regular RPMI medium (11.2 mM glucose) supplemented with 10% heat-treated fetal calf serum (FCS), 100 IU/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, 50 M -mercaptoethanol, and 10 mM HEPES (pH 7.4). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture INS-1 cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007585:Cell Culture [Laboratory Procedure]
           cells culture
   760   C0007634:Cell [Cell]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "grown in regular RPMI medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0205272:Regular [Qualitative Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "(11.2 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "supplemented with 10% heat-treated fetal calf serum (FCS),"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0015965:Fetal [Embryonic Structure]
   744   C0018837:Heat [Natural Phenomenon or Process]
   744   C0229671:Serum [Body Substance]
   744   C0230445:Calf [Body Location or Region]
   744   C0521457:Fetal [Functional Concept]
   744   C1305418:Calf [Body Part, Organ, or Organ Component]
   744   C1522326:Treated [Functional Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   711   C0242295:Supplement [Food]
   711 E C1292734:TREAT [Functional Concept]
   711   C1947943:Supplement [Intellectual Product]
   711   C2348609:Supplement [Functional Concept]

Phrase: "100 IU/ml penicillin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]
   756   C2346524:100 IU/mL [Quantitative Concept]

Phrase: "100 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "2 mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1 mM sodium pyruvate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   812   C0034354:pyruvate [Organic Chemical]
   812   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "50"

Phrase: "M -"

Phrase: "mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "10 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.33: When cells were 80% confluent, they were washed twice with Krebs-Ringer bicarbonate (KRB) buffer (pH 7.4) containing 5 mM glucose and 0.07% BSA and incubated for an additional 2 d in RPMI medium containing 5 mM glucose and 10% FCS. 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "80% confluent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205200:Confluent [Qualitative Concept]

Phrase: "they"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Krebs-Ringer bicarbonate (KRB) buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0973231:Bicarbonate [Inorganic Chemical]
   753   C1720725:Twice [Intellectual Product]
   753   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   753   C1948050:Twice [Quantitative Concept]
   753   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.07% BSA"

Phrase: "and"

Phrase: "incubated for an additional 2 d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1524062:Additional [Functional Concept]

Phrase: "in RPMI medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "10% FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.34: The day of the experiment, cells were washed with KRB buffer and incubated for different times at 37 C in RPMI medium containing 5 mM glucose in the presence of 10% FCS or in the absence of serum with 0.5% defatted BSA with or without fatty acids and staurosporine. 

Phrase: "The day of the experiment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with KRB buffer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0973231:Bicarbonate [Inorganic Chemical]
   753   C1548982:Washed [Idea or Concept]
   753   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   753   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]
   719 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "incubated for different times"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0040223:times [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1632851:Times [Quantitative Concept]
   770   C1705242:Different [Qualitative Concept]
   767   C1442103:Time Difference [Temporal Concept]
   767   C1547049:*Time Difference [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "at 37 C in RPMI medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0009458:Medium [Intellectual Product]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mM glucose in the presence of 10% FCS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0202041:Serum Glucose [Laboratory Procedure]
   754   C3534430:Glucose.serum [Laboratory or Test Result]
   738   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or in the absence of serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0229671:Serum [Body Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "with 0.5% defatted BSA"

Phrase: "with"

Phrase: "or without fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "staurosporine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.35: The stock solutions of fatty acids bound to BSA were prepared as previously described (15). 

Phrase: "The stock solutions of fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0037633:Solutions [Substance]
   719 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "bound to BSA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "were"

Phrase: "prepared as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.36: Fluorescence-activated cell sorting (FACS) analysis Cells (106) incubated under different experimental conditions were washed in cold PBS and fixed with cold 75% ethanol for 1 h at -20 C. 

Phrase: "Fluorescence-activated cell sorting (FACS) analysis Cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   734   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]

Phrase: "(106"

Phrase: ")"

Phrase: "incubated under different experimental conditions"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1705242:Different [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "were"

Phrase: "washed in cold PBS"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0234192:Cold [Physiologic Function]
   770   C1548982:Washed [Idea or Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "fixed with cold 75% ethanol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0001962:Ethanol [Organic Chemical]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0231441:Fixed [Finding]
   760   C0234192:Cold [Physiologic Function]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]

Phrase: "for 1 h at -20 C."
Processing 00000000.tx.37: Attached cells were harvested by centrifugation, resuspended in 0.5 ml PBS containing 0.5% Triton X-100 and 0.05% ribonuclease A, and incubated for 1 h at room temperature. 

Phrase: "Attached cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested by centrifugation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "resuspended in 0.5 ml PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "0.05% ribonuclease A,"

Phrase: "and"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.38: DNA was estimated by measuring red fluorescence after staining with 50 g/ml propidium iodide (Molecular Probes, Inc., Leiden, The Netherlands) for 1530 min at room temperature. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "estimated by measuring red fluorescence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0332575:Red [Finding]
   760   C0444706:measuring [Qualitative Concept]
   760   C0449770:measuring [Quantitative Concept]
   760   C0750572:Estimated [Quantitative Concept]
   760   C1260956:Red [Qualitative Concept]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "after staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with 50 g/ml propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0021966:Iodide [Inorganic Chemical]
   804   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Inc.,"

Phrase: "Leiden,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "for 1530 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.39: Before flow cytometry, samples were passed through a 16-gauge needle to retain aggregates. 

Phrase: "Before flow cytometry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "passed through a 16-gauge needle to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C3640175:Needle Gauge [Quantitative Concept]
   748   C0027551:Needle [Medical Device]
   748   C0456564:Gauge [Spatial Concept]
   748   C1521879:GAGE [Immunologic Factor]
   748   C1704318:Needle [Medical Device]
   748   C1882041:Needle [Spatial Concept]
   748   C2828386:Passed [Finding]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.40: Fluorescence was measured in an EPICS flow cytometer (Coulter, Hialeah, FL), and results were analyzed in real time using the NEURODNA program and displayed as two-parameter histograms: cell number vs. 

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured in an EPICS flow cytometer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0180279:Flow Cytometer [Medical Device]
   753   C0444706:Measured [Qualitative Concept]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1273342:EPIC [Laboratory Procedure]

Phrase: "(Coulter,"

Phrase: "Hialeah,"

Phrase: "FL),"

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "analyzed in real time"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1550177:Real Time [Idea or Concept]
   770   C0040223:Time [Temporal Concept]
   770   C0237400:Real [Qualitative Concept]
   770   C0936012:Analyzed [Research Activity]
   770   C3272377:REAL [Intellectual Product]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NEURODNA program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "and"

Phrase: "displayed as two-parameter histograms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205448:Two [Quantitative Concept]
   760   C0549193:Parameter [Spatial Concept]
   760   C0870432:displayed [Functional Concept]
   760   C1704769:Parameter [Conceptual Entity]
   760   C2350001:Parameter [Quantitative Concept]
   726 E C1705417:Display [Manufactured Object]
   726   C2348974:Histogram [Manufactured Object]

Phrase: ":"

Phrase: "cell number"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007584:Cell Number [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "vs."
Processing 00000000.tx.41: DNA content. 

Phrase: "DNA content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.42: Detection of chromatin condensation Cells were grown on poly-L-lysine-treated glass slides. 

Phrase: "Detection of chromatin condensation Cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "grown on poly-L-lysine-treated glass slides."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0017596:Glass [Manufactured Object]
   744   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0444330:slides [Research Device]
   744   C0747726:POLY [Conceptual Entity]
   744   C1522326:Treated [Functional Concept]
   744   C1947936:Glass [Medical Device]
   711 E C1292734:TREAT [Functional Concept]
   711 E C1705201:Slide [Manufactured Object]
Processing 00000000.tx.43: After incubation with the different test substances, cells were washed twice in PBS and stained with 10 g/ml Hoechst 33342 dye (Molecular Probes, Inc.) for 1 min. 

Phrase: "After incubation"

Phrase: "with the different test substances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substances [Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "stained with 10 g/ml Hoechst 33342 dye"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0062907:Hoechst 33342 [Pharmacologic Substance]
   770   C1300565:g/mL [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   750   C1441607:Hoechst stain [Laboratory Procedure]
   744   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   744   C0439267:g% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Inc.) for 1 min."
Processing 00000000.tx.44: After washing twice in PBS, samples were analyzed using a fluorescence microscope (Carl Zeiss, New York, NY). 

Phrase: "After"

Phrase: "washing twice in PBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441648:Washing [Activity]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fluorescence microscope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Carl Zeiss,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: DNA ladder analysis After cell centrifugation at 300 x g, cell pellets were quickly resuspended in 50 mM Tris (pH 8.0), 50 mM NaCl, 10 mM EGTA, 0.5% sodium dodecyl sulfate, and 200 g/ml proteinase K, and DNA was extracted with phenol-chloroform-isoamyl alcohol (25:24:1) and precipitated in 2.5 vol ethanol (16). 

Phrase: "DNA ladder analysis After cell centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0200898:DNA analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "at 300 x g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "quickly"

Phrase: "resuspended in 50 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]

Phrase: "(pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "50 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "10 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.5% sodium dodecyl sulfate,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   853   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   840   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "200 g/ml proteinase K,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1622131:proteinase [Molecular Function]
   804   C1708601:K' [Quantitative Concept]
   804   C1947941:Proteinase [Enzyme]

Phrase: "and"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted with phenol-chloroform-isoamyl alcohol"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0064032:Isoamyl alcohol [Organic Chemical]
   753   C0001962:ALCOHOL [Organic Chemical]
   753   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   753   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "(25"

Phrase: ":"

Phrase: "24"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "precipitated in 2.5 vol ethanol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001962:Ethanol [Organic Chemical]
   753   C0449468:VOL [Quantitative Concept]
   753   C0560268:vol% [Quantitative Concept]
   753   C1690016:% vol [Qualitative Concept]
   719   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.46: DNA was resolved in 1.5% agarose gel containing ethidium bromide and visualized in a transilluminator. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "resolved in 1.5% agarose gel containing ethidium bromide"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   764   C1706746:Agarose Gel [Research Device]
   742   C0006222:Bromide [Inorganic Chemical]
   742   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0036681:Agarose [Carbohydrate]
   742   C0332256:Containing [Functional Concept]
   742   C1382104:Gel [Substance]
   742   C1514893:Resolved [Idea or Concept]
   742   C2699488:Resolved [Conceptual Entity]
   742   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "visualized in a transilluminator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0184035:Transilluminator [Medical Device]
   770   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.47: Superoxide anion (O2.-) production and mitochondrial membrane potential determinations For superoxide determinations, cells were gently resuspended in a KRB buffer, collected by centrifugation at 300 x g, resuspended in KRB, and incubated at room temperature with 1 g/ml dihydroethidine (Molecular Probes, Inc.) for 2 min. 

Phrase: "Superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "(O2.-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "mitochondrial membrane potential determinations For superoxide determinations,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "resuspended in a KRB buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0973231:Bicarbonate [Inorganic Chemical]
   748   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   748   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "at 300 x g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "resuspended in KRB,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   760   C0973231:Bicarbonate [Inorganic Chemical]
   760   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   760   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "with 1 g/ml dihydroethidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1741836:dihydroethidine [Organic Chemical]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Inc.) for 2 min."
Processing 00000000.tx.48: After two washes in PBS, the change in fluorescence from blue to red (oxidized dye) was determined in an EPICS flow cytometer. 

Phrase: "After two washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "the change in fluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "from blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "to red (oxidized dye"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1509471:Red dye [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "was"

Phrase: "determined in an EPICS flow cytometer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0180279:Flow Cytometer [Medical Device]
   753   C0806140:Flow [Natural Phenomenon or Process]
   719   C1273342:EPIC [Laboratory Procedure]
Processing 00000000.tx.49: For mitochondrial potential measurements, cells were harvested by centrifugation in KRB, resuspended, and incubated for 5 min at room temperature with 10 g/ml rhodamine 123 (Molecular Probes, Inc.). 

Phrase: "For mitochondrial potential measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "in KRB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   827   C0973231:Bicarbonate [Inorganic Chemical]
   827   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "resuspended,"

Phrase: "and"

Phrase: "incubated for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with 10 g/ml rhodamine 123"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.50: After two washes in PBS, fluorescence was determined in an EPICS cytometer. 

Phrase: "After two washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "determined in an EPICS cytometer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1273342:EPIC [Laboratory Procedure]
Processing 00000000.tx.51: Subcellular fractionation After incubation, cells were scraped from the dishes, collected by centrifugation at 700 x g for 4 min at 4 C, washed twice with ice-cold PBS, and centrifuged at 700 x g for 4 min. 

Phrase: "Subcellular fractionation After incubation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1656251:subcellular fractionation [Laboratory Procedure]
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "scraped from the dishes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0184933:scraped [Therapeutic or Preventive Procedure]
   770   C0444082:scraped [Body Substance]
   737   C0020498:DISH [Disease or Syndrome]

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "at 700 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "for 4 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C,"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold PBS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720725:Twice [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "centrifuged at 700 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 4 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.52: Cell pellets were resuspended in 50 l extraction buffer containing 220 mM mannitol, 68 mM sucrose, 50 mM HEPES (pH 7.5), 50 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM dithiothreitol, 10 g/ml phenylmethylsulfonylfluoride (PMSF), 10 g/ml pepstatin A, and 10 g/ml leupeptin. 

Phrase: "Cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 50 l extraction buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0185115:Extraction [Therapeutic or Preventive Procedure]
   753   C0684295:extraction [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "220 mM mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "68 mM sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "50 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "50 mM KCl,"

Phrase: "5 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "2 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "10 g/ml phenylmethylsulfonylfluoride (PMSF),"

Phrase: "10 g/ml pepstatin A,"

Phrase: "and"

Phrase: "10 g/ml leupeptin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.53: After incubation on ice for 30 min, cells were homogenized by 50 strokes of a polypropylene homogenizer (motor-driven micropistil) and spun at 15,000 x g for 15 min. 

Phrase: "After incubation"

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "homogenized by 50 strokes of a polypropylene homogenizer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0032582:Polypropylene [Biomedical or Dental Material,Organic Chemical]
   744   C0038454:Strokes [Disease or Syndrome]
   744   C0181200:homogenizer [Medical Device]

Phrase: "(motor-driven micropistil"

Phrase: ")"

Phrase: "and"

Phrase: "spun at 15,000 x g"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1446863:Spun [Laboratory Procedure]
   719 E C1415347:SPIN [Gene or Genome]
   719 E C1823107:SPIN [Gene or Genome]

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.54: Supernatants (cytosolic fraction) were then recovered and assayed for glutamate dehydrogenase (GDH) enzymatic activity (17). 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "(cytosolic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "assayed for glutamate dehydrogenase (GDH) enzymatic activity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   820   C1151821:glutamate dehydrogenase activity [Molecular Function]
   790   C0017786:Glutamate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2267219:Enzymatic Activity [Molecular Function]
   767   C2717977:Enzymatic Assay [Laboratory Procedure]
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.55: Less than 5% of the total cellular GDH activity (mitochondrial marker) was detected in supernatants after sample homogenization. 

Phrase: "Less than 5% of the total cellular GDH activity"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   782   C1151821:glutamate dehydrogenase activity [Molecular Function]
   760   C0017786:Glutamate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439092:Less Than [Intellectual Product]
           less
   739   C0007634:Cellular [Cell]
   739   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   739   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0178539:Cellular [Functional Concept]
   739   C0205177:Activity [Functional Concept]
   739   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439167:% activity [Quantitative Concept]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0441655:Activity [Activity]
   739   C0547044:Less [Qualitative Concept]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "(mitochondrial marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "detected in supernatants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C1550101:Supernatant [Body Substance]

Phrase: "after sample homogenization."
Processing 00000000.tx.56: The yield of GDH in both fractions was not affected by fatty acids or staurosporine. 

Phrase: "The yield of GDH"

Phrase: "in both fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by fatty acids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "staurosporine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.57: Western blot analysis of cytochrome c, AIF, and caspase-2 Aliquots of 15 g protein of cytosolic fractions and 10 g protein of particulate fractions were boiled for 30 min for cytochrome c and for 3 min for AIF and caspase-2 measurements, resolved on 12.5% sodium dodecyl sulfate-polyacrylamide gels, and then blotted to polyvinylidene difluoride (PVDF) membranes (Amersham Pharmacia Biotech, Little Chalfont, UK). 

Phrase: "Western blot analysis of cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "AIF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "caspase-2 Aliquots of 15 g protein of cytosolic fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1510844:Aliquot [Quantitative Concept]

Phrase: "and"

Phrase: "10 g protein of particulate fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   783 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "boiled for 30 min"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "for cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and for 3 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "for AIF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "caspase-2 measurements,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242485:measurements [Functional Concept]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resolved on 12.5% sodium dodecyl sulfate-polyacrylamide gels,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   764   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   764   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   762   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0017243:Gels [Biomedical or Dental Material]
   742   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0038720:Sulfate [Inorganic Chemical]
   742   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   742   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   742   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1514893:Resolved [Idea or Concept]
   742   C2699488:Resolved [Conceptual Entity]
   742   C3536965:SULFATE [Element, Ion, or Isotope]
   708 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "blotted to polyvinylidene difluoride (PVDF) membranes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Little Chalfont,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.58: Membranes were incubated overnight at 4 C with an anticytochrome c monoclonal antibody (1:2,000; 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with an anticytochrome c monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2,000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.59: BD Pharmingen, San Diego, CA), an anti-AIF polyclonal antibody (1:5,000; 

Phrase: "BD Pharmingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA),"

Phrase: "an anti-AIF polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.60: Santa Cruz Biotechnology, Inc., Santa Cruz, CA), or an anticaspase-2L polyclonal antibody (1:200; 

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "or"

Phrase: "an anticaspase-2L polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.61: Santa Cruz Biotechnology, Inc.). 

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.62: After removal of excess primary antibody, membranes were incubated for 2 h with conjugated peroxidase antimouse IgG (Sigma, St. 

Phrase: "After removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of excess primary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with conjugated peroxidase antimouse IgG (Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1719918:Sigma [Intellectual Product]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.63: Louis, MO; 

Phrase: "Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.64: 1:10,000) for cytochrome c, with antigoat IgG (Sigma; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")"

Phrase: "for cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "with antigoat IgG"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.65: 1:5,000) for AIF, or with antirabbit IgG (Sigma; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "for AIF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "or with antirabbit IgG"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.66: 1:500) for caspase-2. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "for caspase-2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.67: Bound antibodies were detected by enhanced chemiluminescence using an enhanced chemiluminescence kit (Amersham Pharmacia Biotech). 

Phrase: "Bound antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected by enhanced chemiluminescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0442726:Detected [Finding]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2349975:Enhanced [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enhanced chemiluminescence kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.68: Poly(ADP-ribose) polymerase (PARP) cleavage detection Total proteins from cells incubated for 36 h under the different experimental conditions were extracted with a buffer containing 62.5 mM Tris (pH 6.8), 0.5 mM PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, 5 g/ml pepstatin A, 5 g/ml antipain, 5% -mercaptoethanol, 2% sodium dodecyl sulfate, 10% glycerol, 6 M urea, and 0.00125% bromophenol blue and incubated for 8 min at 65 C. 

Phrase: "Poly(ADP-ribose) polymerase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
  1000   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   923   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001461:ADP Ribose [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035549:Ribose [Carbohydrate]
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0523452:ADP [Laboratory Procedure]
   812   C0747726:POLY [Conceptual Entity]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: ")"

Phrase: "cleavage detection Total proteins from cells"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   783   C1441375:Cells.total [Cell]
   767   C0439177:Protein.total [Quantitative Concept]
   767   C0597304:Protein Cleavage [Molecular Function]
   756 E C0555903:Total protein [Laboratory Procedure]
   756 E C1261360:total protein [Laboratory or Test Result]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "incubated for 36 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "under the different experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "extracted with a buffer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "62.5 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "(pH 6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "0.5 mM PMSF,"

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "5 g/ml pepstatin A,"

Phrase: "5 g/ml antipain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003403:Antipain [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5% -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "2% sodium dodecyl sulfate,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "6 M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.00125% bromophenol blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006247:Bromophenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]

Phrase: "and"

Phrase: "incubated for 8 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 65 C."
Processing 00000000.tx.69: Aliquots of 15 g protein were immediately resolved on 10% sodium dodecyl sulfate-polyacrylamide gels. 

Phrase: "Aliquots of 15 g protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "resolved on 10% sodium dodecyl sulfate-polyacrylamide gels."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   770   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   770   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   767   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0017243:Gels [Biomedical or Dental Material]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1514893:Resolved [Idea or Concept]
   744   C2699488:Resolved [Conceptual Entity]
   744   C3536965:SULFATE [Element, Ion, or Isotope]
   711 E C1382104:Gel [Substance]
Processing 00000000.tx.70: The time between cell lysis and the start of electrophoresis was less than 30 min so as to minimize PARP cleavage during manipulations. 

Phrase: "The time between cell lysis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "the start of electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439659:Start [Temporal Concept]

Phrase: "was"

Phrase: "less than 30 min so"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0439092:Less Than [Intellectual Product]
           less
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0547044:Less [Qualitative Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "as to"

Phrase: "minimize"

Phrase: "PARP cleavage during manipulations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
Processing 00000000.tx.71: Gels were then blotted to PVDF membranes that were incubated overnight at 4 C with an anti-PARP monoclonal antibody (1:1000; 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "blotted to PVDF membranes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "that"

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with an anti-PARP monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.72: Oncogene Research Products, Boston, MA). 

Phrase: "Oncogene Research Products,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0029005:Oncogene Products [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.73: After removal of the primary antibody, membranes were incubated for 2 h with conjugated peroxidase antimouse IgG (Sigma; 

Phrase: "After removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of the primary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with conjugated peroxidase antimouse IgG (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1719918:Sigma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.74: 1:5000). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: ")."
Processing 00000000.tx.75: Bound antibodies were detected by chemiluminescence. 

Phrase: "Bound antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected by chemiluminescence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0442726:Detected [Finding]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.76: Bcl-2, Bax, and iNOS detection Induction of iNOS was performed by incubating INS-1 cells for 24 h in the presence of 50 IU/ml rat IL-1, 100 IU/ml rat IFN, and 50 ng/ml rat TNF- (R\|[amp ]\|D Systems, Inc., Weisbaden, Germany). 

Phrase: "Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "Bax,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "iNOS detection Induction of iNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed by incubating"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   790   C1439852:incubating [Laboratory Procedure]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 50 IU/ml rat IL-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C1514732:Rat-1 [Cell]
   827   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0020898:IL [Geographic Area]
   799   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0022271:IL [Geographic Area]

Phrase: "100 IU/ml rat IFN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C2346524:100 IU/mL [Quantitative Concept]

Phrase: "and"

Phrase: "50 ng/ml rat TNF- (R\\|[amp ]\\|D Systems,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   758   C0449913:System [Functional Concept]
   758   C1553451:System [Manufactured Object]
   758   C1704459:System [Medical Device]
   708 E C0205373:Systemic [Functional Concept]
   700   C1636666:ng/d [Quantitative Concept]

Phrase: "Inc.,"

Phrase: "Weisbaden,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.77: Total proteins from cells incubated for 36 h for Bcl-2 and Bax and for 24 h for iNOS under the different experimental conditions were extracted with a buffer containing 20 mM Tris (pH 7.5), 137 mM NaCl, 5 mM MgCl2, 5 mM EDTA, 5 mM EGTA, 0.5 mM PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, 5 g/ml pepstatin A, 5 g/ml antipain, 10 mM -mercaptoethanol, and 1% Triton X-100. 

Phrase: "Total proteins from cells"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   819   C1441375:Cells.total [Cell]
   802   C0439177:Protein.total [Quantitative Concept]
   799 E C0555903:Total protein [Laboratory Procedure]
   799 E C1261360:total protein [Laboratory or Test Result]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "incubated for 36 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "for iNOS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0669372:Inducible NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0132555:NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase

Phrase: "under the different experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "extracted with a buffer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "137 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.5 mM PMSF,"

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "5 g/ml pepstatin A,"

Phrase: "5 g/ml antipain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003403:Antipain [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10 mM -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "1% Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]
Processing 00000000.tx.78: Aliquots of 25 g protein were resolved on 12.5% sodium dodecyl sulfate-polyacrylamide gels for Bcl-2 and Bax and 7,5% SDS gels for iNOS, and then blotted to PVDF membranes that were then incubated overnight at 4 C with an anti-Bcl-2 polyclonal antibody (1:2000; 

Phrase: "Aliquots of 25 g protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on 12.5% sodium dodecyl sulfate-polyacrylamide gels"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   764   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   764   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   762   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0017243:Gels [Biomedical or Dental Material]
   742   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0038720:Sulfate [Inorganic Chemical]
   742   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   742   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   742   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1514893:Resolved [Idea or Concept]
   742   C2699488:Resolved [Conceptual Entity]
   742   C3536965:SULFATE [Element, Ion, or Isotope]
   708 E C1382104:Gel [Substance]

Phrase: "for Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "7,"

Phrase: "5% SDS gels for iNOS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0017243:Gels [Biomedical or Dental Material]
   714 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "blotted to PVDF membranes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "that"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with an anti-Bcl-2 polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.79: Santa Cruz Biotechnology, Inc.), an anti-Bax polyclonal antibody (1:500; 

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."

Phrase: ")"

Phrase: ","

Phrase: "an anti-Bax polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.80: Santa Cruz Biotechnology, Inc.), or an anti-macrophage iNOS polyclonal antibody (1:2000; 

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "an anti-macrophage iNOS polyclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   877   C0312598:Macrophage antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.81: Transduction Laboratories, Inc., Lexington, KY). 

Phrase: "Transduction Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "Lexington,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.82: After removal of the primary antibody, membranes were incubated for 2 h with conjugated peroxidase antirabbit IgG (Sigma; 

Phrase: "After removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of the primary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with conjugated peroxidase antirabbit IgG"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.83: 1:5000). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: ")."
Processing 00000000.tx.84: Bound antibodies were detected using an enhanced chemiluminescence kit. 

Phrase: "Bound antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enhanced chemiluminescence kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0812225:KIT [Medical Device]
   827   C1150635:KIT [Molecular Function]
   827   C1705212:Kit [Medical Device]
   827   C1705213:KIT [Medical Device]
   827   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.85: NO production NO was determined as nitrite by the method of Green et al. 

Phrase: "NO production NO"

Phrase: "was"

Phrase: "determined as nitrite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028137:Nitrite [Chemical Viewed Structurally]
   790   C1384115:Nitrite [Inorganic Chemical]

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Green et al."
Processing 00000000.tx.86: (18) with modifications. 

Phrase: "(18"

Phrase: ")"

Phrase: "with modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.87: Briefly, 100 l of a 1:1 mix of 1% N-1-naphtyl-ethylenediamine dihydrochloride and 10% sulfonilamide (Sigma) were added to 50 l culture supernatant. 

Phrase: "Briefly,"

Phrase: "100 l of a 1"

Phrase: ":"

Phrase: "1 mix of 1% N-1-naphtyl-ethylenediamine dihydrochloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205430:Mix [Functional Concept]
   742   C1421951:MIX [Gene or Genome]
   742   C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "10% sulfonilamide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038760:sulfonilamide [Organic Chemical]
   861   C0599503:Sulfonilamide [Antibiotic,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "added to 50 l culture supernatant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1524062:Added [Functional Concept]
   753   C1550101:Supernatant [Body Substance]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1883712:Add [Functional Concept]
Processing 00000000.tx.88: After 20-min incubation at 37 C in the absence of light, absorbance was measured at 540 nm and compared with standard curves of different concentrations of NaNO2 in the presence of the different test substances added to the cells to correct for interferences. 

Phrase: "After 20-min incubation"

Phrase: "at 37 C in"

Phrase: "the absence of light,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "measured at 540 nm"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "compared with standard curves of different concentrations of NaNO2"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0086045:Concentrations [Mental Process]
   742   C1442989:Standard [Qualitative Concept]
   742   C1705242:Different [Qualitative Concept]
   742   C1707455:Compared [Activity]
   742   C2828392:Standard [Intellectual Product]
   708   C0205134:Curve [Spatial Concept]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the different test substances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substances [Substance]

Phrase: "added to the cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1524062:Added [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "to correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for interferences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0521102:Interference [Qualitative Concept]
Processing 00000000.tx.89: Reagents RPMI 1640 medium, FCS, and culture supplements were purchased from Life Technologies, Inc. 

Phrase: "Reagents RPMI 1640 medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "culture supplements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242295:Supplement [Food]
   827   C1947943:Supplement [Intellectual Product]
   827   C2348609:Supplement [Functional Concept]

Phrase: "were"

Phrase: "purchased from Life Technologies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.90: (Gaithersburg, MD). 

Phrase: "(Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.91: Staurosporine, fatty acids, and protease inhibitors were obtained from Sigma (St. Louis, MO). 

Phrase: "Staurosporine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "obtained from Sigma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.92: All other reagents were of analytical grade. 

Phrase: "All"

Phrase: "other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were of analytical grade."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441800:Grade [Classification]
   770   C0919553:Grade [Classification]
   770   C0936012:Analytical [Research Activity]
   770   C3244287:grade [Finding]
Processing 00000000.tx.93: Statistical analysis Data were expressed as the mean  SEM and were analyzed by t test.  

Phrase: "Statistical analysis Data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C2828391:statistical data [Quantitative Concept]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "were"

Phrase: "expressed as the mean  SEM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "analyzed by t test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.94: Results Top Abstract Introduction Materials and Methods Results Discussion References  To better understand the mechanism by which high concentrations of fatty acids may be toxic to -cells, we decided to use INS-1() cells as a model because the amount of available cellular material allows more biochemical determinations to be performed than with isolated islets. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "To better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the mechanism by which high concentrations of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "toxic to -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use INS-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C1414685:INS-1 [Gene or Genome]
   882   C3538717:INS-1 [Gene or Genome]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "("

Phrase: ")"

Phrase: "cells as a model"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "because"

Phrase: "the amount of available cellular material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "more biochemical determinations to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]

Phrase: "be"

Phrase: "performed than"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with isolated islets."
Processing 00000000.tx.95: In addition, cell death measurements in isolated islets are rendered difficult due to the high background of central necrosis. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "cell death measurements in isolated islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:measurements [Functional Concept]

Phrase: "are"

Phrase: "rendered"

Phrase: "difficult due to the high background of central necrosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332218:Difficult [Qualitative Concept]
Processing 00000000.tx.96: In initial experiments we tested the actions of fatty acids in the presence of 10% FCS, but noticed that fatty acids were barely toxic to INS cells under our culture conditions and time span (36 h). 

Phrase: "In initial experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the actions of fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441472:actions [Functional Concept]
   726 E C3266814:Action [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10% FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "but"

Phrase: "noticed"

Phrase: "that fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "barely toxic to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600688:toxic [Injury or Poisoning]
   790   C1407029:Toxic [Qualitative Concept]

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "under our culture conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "time span"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0040223:Time [Temporal Concept]
   861   C1711300:Span [Conceptual Entity]
   861   C2700613:Span [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "(36 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.97: We therefore tested their actions in the absence of serum (14), a situation known to alter cell survival in various systems, and noticed that fatty acids were toxic to the -cell under this experimental condition where cells are already "fragilized." 

Phrase: "We therefore"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "their actions in the absence of serum"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441472:actions [Functional Concept]
   714 E C3266814:Action [Activity]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "a situation"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "cell survival in various systems,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007620:Cell Survival [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "noticed"

Phrase: "that fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "toxic to the -cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "under this experimental condition where cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "already ""fragilized."""
Processing 00000000.tx.98: This may in part mimic the situation in type 1 or 2 diabetes where -cells have encountered the assault of various stressful conditions, such as cytokines and oxidative stress (1, 19, 20, 21). 

Phrase: "This"

Phrase: "may in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "mimic"

Phrase: "the situation in type 1"

Phrase: "or"

Phrase: "2 diabetes where -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "encountered"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0545082:Encounter [Behavior]
   966   C1512346:encounter [Health Care Activity]
   966   C1947978:Encounter [Behavior]

Phrase: "the assault of various stressful conditions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004063:Assault [Injury or Poisoning]

Phrase: "such as cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "19,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.99: FACS analysis of (INS-1)-cells incubated in the presence of different nutrients and test substances One way to study cell survival and death is by FACS analysis, which also provides information about cell cycle progression. 

Phrase: "FACS analysis of (INS-1"

Phrase: ")-"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of different nutrients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0678695:Nutrients [Food]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1705242:Different [Qualitative Concept]
   714 E C2347375:Nutrient [Conceptual Entity]

Phrase: "and"

Phrase: "test substances One way to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439861:Substances [Substance]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "is by FACS analysis,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   853   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   778   C0007616:Cell Sorting [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0237886:Sorting [Mental Process]
   748   C0700314:sorting [Cell Function]
   748   C0936012:Analysis [Research Activity]
   748   C1269647:Cell [Cell]
   748   C1524024:analysis [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1879547:Activated [Activity]
   748   C1947906:Sorting [Activity]
   748   C1948049:Cell [Spatial Concept]
   714 E C1515877:Activate [Functional Concept]

Phrase: "which also"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "information about cell cycle progression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]
Processing 00000000.tx.100: INS cells incubated with or without serum and various concentrations of glucose and fatty acids were then stained with propidium iodide and sorted according to DNA content. 

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "or without serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "various concentrations of glucose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0427743:concentrations glucose [Laboratory Procedure]
   819   C1287281:concentrations glucose [Laboratory or Test Result]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained with propidium iodide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0021966:Iodide [Inorganic Chemical]
   770   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "sorted according to DNA content."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0237886:sorted [Mental Process]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]
   760   C0680240:according [Social Behavior]
   760   C0700314:sorted [Cell Function]
   760   C1947906:Sorted [Activity]
Processing 00000000.tx.101: Staurosporine was used as a positive control, because this drug efficiently induces apoptosis in several cell types (22, 23). 

Phrase: "Staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used as a positive control,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "this drug efficiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C1254351:Drug [Pharmacologic Substance]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in several cell types"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.102: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.103: 1, A and B, cells incubated with 5 mM glucose in the presence of the growth factors supplied by the serum are mainly quiescent in the G0 phase, with very low levels of subdiploid (cell death) events or DNA synthesis (S phase). 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with 5 mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "supplied by the serum"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C1999230:Supplied [Activity]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1875802:SUPPLY [Medical Device]

Phrase: "are"

Phrase: "mainly quiescent in the G0 phase,"

Phrase: "with very low levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0442811:Very low [Finding]

Phrase: "of subdiploid"

Phrase: "(cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "or"

Phrase: "DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "(S phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0080129:S Phase [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.104: The subdiploid population increased when serum was absent from culture medium. 

Phrase: "The subdiploid population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "absent from culture medium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]
Processing 00000000.tx.105: No major changes where observed when the glucose concentration was increased to 25 mM, except for a significant (P < 0.05) rise in the cell population corresponding to the S phase of the cell cycle, thus confirming the mitogenic action of the sugar. 

Phrase: "No major changes where"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "increased to 25 mM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "except for a significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "rise in the cell population"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "corresponding to the S phase of the cell cycle,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   784   C1516337:Cell Cycle Phase [Cell Function]
   764   C0007586:Cell Cycle [Cell Function]
   764   C0080129:S Phase [Temporal Concept]
   764   C1155839:Cell Cycle [Cell Function]
   762   C2963400:Cell phase [Temporal Concept]
   742   C0007634:Cell [Cell]
   742   C0205390:Phase [Temporal Concept]
   742   C1269647:Cell [Cell]
   742   C1511572:Cycle [Temporal Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "thus"

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the mitogenic action of the sugar."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]
Processing 00000000.tx.106: The addition of oleate, palmitate, and staurosporine to the serum-deprived culture medium dramatically increased the number of subdiploid events in association with a decrease in the G0 population. 

Phrase: "The addition of oleate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "palmitate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "staurosporine to the serum-deprived culture medium dramatically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the number of subdiploid events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "in the G0 population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.107: Oleate, but not palmitate, significantly increased the number of cells in the S phase with a poor progression to the M phase. 

Phrase: "Oleate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "but"

Phrase: "not palmitate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030233:palmitate [Lipid]
   861   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the number of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in the S phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]

Phrase: "with a poor progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "to the M phase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007591:M Phase [Cell Function]
  1000   C0026255:M Phase [Cell Function]
   861   C0205390:Phase [Temporal Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.108: The increased level of S phase events noticed in oleate-treated cells is comparable to that caused by 25 mM glucose. 

Phrase: "The increased level of S phase events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0441471:Events [Event]
   799   C3541888:Events [Classification]

Phrase: "noticed in oleate-treated cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0133788:oleate [Lipid]
   760   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "comparable to that"

Phrase: "caused by 25 mM glucose."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.109: This observation is in accordance with tritiated thymidine experiments in INS cells incubated under similar experimental conditions (15). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is in accordance with tritiated thymidine experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "in"

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated under similar experimental conditions"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1517586:Experimental [Qualitative Concept]
   760   C2348205:Similar [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.110: Together the results indicate that serum deprivation over 36 h induces a modest (INS-1)-cell death that is markedly enhanced by fatty acids, but not by elevated glucose. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that serum deprivation over 36 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0871712:Deprivation [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a modest"

Phrase: "("

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "enhanced by fatty acids,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   770   C2349975:Enhanced [Activity]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "but"

Phrase: "not by elevated glucose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:Elevated [Qualitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.111: In addition, palmitate and oleate cause differential aberrations in cell cycle phase distribution. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "differential aberrations in cell cycle phase distribution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0520511:distribution [Idea or Concept]
   795   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.112: View larger version (46K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.113: A, FACS analysis of INS-1 cells incubated in the presence of various test substances. 

Phrase: "A,"

Phrase: "FACS analysis of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   716   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of various test substances."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0392366:test [Intellectual Product]
   744   C0439861:Substances [Substance]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.114: Cells were cultured for 2 d with 5 mM glucose in the presence of 10% FCS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 2 d"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "with 5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10% FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.115: Cells were subsequently incubated for 36 h in culture medium containing 5 mM glucose plus 10% FCS (G5/FCS) or medium containing 0.5% defatted BSA with 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose plus 0.5 mM oleate, 0.5 mM palmitate, and 0.2 M staurosporine. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "incubated for 36 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "medium containing 0.5% defatted BSA with 5 mM glucose"

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose plus 0.5 mM oleate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0133788:oleate [Lipid]
   793   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "0.5 mM palmitate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "0.2 M staurosporine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.116: At the end of the incubation period, cells were harvested, and FACS analysis was performed. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation period,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:Incubation period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "and"

Phrase: "FACS analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.117: The figure shows histograms from a representative experiment. 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "histograms from a representative experiment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2348974:Histogram [Manufactured Object]
Processing 00000000.tx.118: SD, Subdiploid population; 

Phrase: "SD,"

Phrase: "Subdiploid population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: ";"
Processing 00000000.tx.119: G0, diploid population in the G0 phase of the cell cycle; 

Phrase: "G0,"

Phrase: "diploid population in the G0 phase of the cell cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032659:Population [Quantitative Concept]
   739   C1257890:Population [Population Group]

Phrase: ";"
Processing 00000000.tx.120: S, cell population in the S phase; 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "cell population in the S phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]

Phrase: ";"
Processing 00000000.tx.121: M, tetraploid population in the M phase. 

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "tetraploid population in the M phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]
Processing 00000000.tx.122: B, Quantitation of the FACS analysis of INS-1 cells cultured in the presence of various test substances. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Quantitation of the FACS analysis of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709793:Quantitation [Quantitative Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in the presence of various test substances."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0392366:test [Intellectual Product]
   744   C0439861:Substances [Substance]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.123: Values shown are the mean  SEM of three independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of three independent experiments."
Processing 00000000.tx.124: *, P < 0.05, vs. control (G5).  

Phrase: "*,"

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.125: The percentage of live cells (determined from the total and subdiploid dead cell populations in FACS analysis) was evaluated under different conditions over a 72-h period (Fig. 2A). 

Phrase: "The percentage of live cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "("

Phrase: "determined from the total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "subdiploid dead cell populations in FACS analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1514228:Population Analysis [Research Activity]
   739   C0032659:Population [Quantitative Concept]
   739   C1257890:Population [Population Group]

Phrase: ")"

Phrase: "was"

Phrase: "evaluated under different conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0220825:Evaluated [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "over a 72-h period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.126: Dead cells reached a value of approximately 10% at either 5 or 25 mM glucose after 36 h. 

Phrase: "Dead cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a value of approximately 10%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522609:Value [Quantitative Concept]

Phrase: "at either 5"

Phrase: "or"

Phrase: "25 mM glucose after 36 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.127: However, death events strongly increased under the same period in cells incubated in the presence of palmitate or oleate or with the positive control staurosporine. 

Phrase: "However,"

Phrase: "death events strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "increased under the same period"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0439531:/period [Temporal Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of palmitate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030233:palmitate [Lipid]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "or"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "or with the positive control staurosporine."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1883676:Positive Control [Conceptual Entity]
   753   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   753   C0243148:control [Qualitative Concept]
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2825490:Positive [Qualitative Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.128: The percentage of dead cells in all conditions, except for incubation in the presence of staurosporine, remained relatively stable during the 36- to 60-h period. 

Phrase: "The percentage of dead cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in all conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "except for incubation"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of staurosporine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "remained"

Phrase: "relatively stable during the 36-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stable [Qualitative Concept]
   760   C1547311:Stable [Intellectual Product]

Phrase: "to 60-h period."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.129: Incubation times longer than 60 h without serum caused cell detachment and increased cell death in all conditions. 

Phrase: "Incubation times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "longer than 60 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0205166:Long [Qualitative Concept]
   737   C1706317:Long [Qualitative Concept]

Phrase: "without serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "cell detachment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0541879:detachment [Mental Process]
   861   C0595950:Detachment [Pathologic Function]
   789 E C0687118:Detached [Functional Concept]
   789 E C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "increased cell death in all conditions."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.130: The data indicate that serum-deprived (INS-1)-cells enter a death process that is markedly accelerated by fatty acids. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that serum-deprived"

Phrase: "("

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "a death process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "is"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "accelerated by fatty acids."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   770   C0521110:Accelerated [Functional Concept]
   737 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.131: View larger version (23K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.132: Effect of a constant or transient exposure of INS-1 cells to elevated fatty acids on -cell death. 

Phrase: "Effect of a constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "transient exposure of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "to elevated fatty acids on -cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.133: A, Time course of -cell death in INS-1 cells cultured with various test substances. 

Phrase: "A,"

Phrase: "Time course of -cell death in"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C1301931:Time of death [Clinical Attribute]
           death time
   814   C2706679:Time of death [Clinical Attribute]
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured with various test substances."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0439861:Substances [Substance]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.134: Cells were incubated for different times in medium containing 0.5% defatted BSA in the presence of 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose plus 0.5 mM oleate (Ol); 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for different times in medium containing 0.5% defatted BSA"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   756   C0444499:0/5 [Quantitative Concept]
   738   C0009458:Medium [Intellectual Product]
   738   C0040223:times [Temporal Concept]
   738   C0332256:Containing [Functional Concept]
   738   C0439536:Medium [Quantitative Concept]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1632851:Times [Quantitative Concept]
   738   C1705217:Medium [Substance]
   738   C1705242:Different [Qualitative Concept]
   738   C2700400:Containing [Activity]
   738   C3244283:medium [Intellectual Product]
   704 E C3541383:Time [Temporal Concept]
   701   C1442103:Time Difference [Temporal Concept]
   701   C1547049:*Time Difference [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose plus 0.5 mM oleate (Ol)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0133788:oleate [Lipid]
   793   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.135: 0.5 mM palmitate (Palm); 

Phrase: "0.5 mM palmitate (Palm)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ";"
Processing 00000000.tx.136: and 0.2 M staurosporine (St). 

Phrase: "and"

Phrase: "0.2 M staurosporine (St)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.137: Subsequently, apoptosis and/or necrosis (subdiploid population) were determined by FACS analysis as described in Fig. 

Phrase: "Subsequently,"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and/or"

Phrase: "necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: "(subdiploid population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "determined by FACS analysis"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   853   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   778   C0007616:Cell Sorting [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0237886:Sorting [Mental Process]
   748   C0700314:sorting [Cell Function]
   748   C0936012:Analysis [Research Activity]
   748   C1269647:Cell [Cell]
   748   C1524024:analysis [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1879547:Activated [Activity]
   748   C1947906:Sorting [Activity]
   748   C1948049:Cell [Spatial Concept]
   714 E C1515877:Activate [Functional Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.138: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.139: Each point represents the mean  SEM of three independent experiments. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  SEM of three independent experiments."
Processing 00000000.tx.140: *, P < 0.01; 

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.141: **, P < 0.005 [vs. control (G5)]. 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "["

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.142: B, A 2-h transient incubation of INS cells in the presence of an elevated fatty acid concentration is sufficient to promote -cell death. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "A 2-h transient incubation of"

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of an elevated fatty acid concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "promote -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.143: INS cells were cultured for 2 h in medium containing 0.5% defatted BSA in the presence of 5 mM glucose (G5), 5 mM glucose plus 0.5 mM oleate (Ol), or 0.5 mM palmitate (Palm). 

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 2 h in medium containing 0.5% defatted BSA"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   756   C0444499:0/5 [Quantitative Concept]
   754   C0011744:h 2 [Element, Ion, or Isotope]
   738   C0009458:Medium [Intellectual Product]
   738   C0033727:H+ [Element, Ion, or Isotope]
   738   C0332256:Containing [Functional Concept]
   738   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0439536:Medium [Quantitative Concept]
   738   C0441932:H+ [Classification]
   738   C0564385:/h [Quantitative Concept]
   738   C1705217:Medium [Substance]
   738   C2700400:Containing [Activity]
   738   C3244283:medium [Intellectual Product]
   737   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   704   C0010453:Culture [Idea or Concept]
   704   C0220814:culture [Functional Concept]
   704   C0430400:Culture [Laboratory Procedure]
   704   C2242979:Culture [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "5 mM glucose plus 0.5 mM oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0133788:oleate [Lipid]
   793   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Ol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "0.5 mM palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")."
Processing 00000000.tx.144: Subsequently, media were removed, and incubation was continued for 34 h in fresh medium containing 5 mM glucose plus 0.5% defatted BSA. 

Phrase: "Subsequently,"

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "incubation"

Phrase: "was"

Phrase: "continued for 34 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0549178:Continued [Idea or Concept]
   770   C0564385:/h [Quantitative Concept]

Phrase: "in fresh medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mM glucose plus 0.5% defatted BSA."
Processing 00000000.tx.145: At the end of the incubation period, cells were harvested, and -cell death was determined as described in A. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation period,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:Incubation period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "and -"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.146: Values shown are the mean  SEM of three independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of three independent experiments."
Processing 00000000.tx.147: *, P < 0.01; 

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.148: **, P < 0.005 [vs. control (G5)].  

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "["

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.149: We also incubated INS-1 cells for 36 h in the absence of serum, but exposed them to elevated concentrations of fatty acids for different periods of time, followed by a further incubation in the absence of fatty acids. 

Phrase: "We also incubated INS-1 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 36 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of serum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "but"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "them to elevated concentrations of fatty acids"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0015684:Fatty Acids [Lipid]
   748   C0001128:Acids [Chemical]
   748   C0086045:Concentrations [Mental Process]
   748   C0205250:Elevated [Qualitative Concept]
   748   C3163633:Elevated [Qualitative Concept]
   714 E C0202406:Acid [Laboratory Procedure]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "for different periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "followed by a further incubation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of fatty acids."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.150: Interestingly, a 2-h transient incubation of cells in the presence of fatty acids was sufficient to trigger the death process after 2436 h (Fig. 2B). 

Phrase: "Interestingly,"

Phrase: "a 2-h transient incubation of cells"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the death process after 2436 h (Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1184743:Process [Body Part, Organ, or Organ Component]
   744   C1522240:Process [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.151: The study of the dose dependence of the effect of fatty acids on (INS-1) cell death indicated that a fixed concentration of BSA (0.5%) and 0.1 mM palmitate or oleate caused a very modest cell death, and 0.3 mM of either fatty acid induced approximately half the death process observed at 0.5 mM. 

Phrase: "The study of the dose dependence of the effect of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0557651:Study [Manufactured Object]
   736   C2603343:Study [Research Activity]

Phrase: "on (INS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720176:On [Functional Concept]
   790   C1720294:On [Intellectual Product]
   716   C1414685:INS-1 [Gene or Genome]
   716   C3538717:INS-1 [Gene or Genome]

Phrase: ")"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "a fixed concentration of BSA (0.5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "0.1 mM palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "or"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a very modest cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "0.3 mM of either fatty acid"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "approximately half"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332232:Approximately [Qualitative Concept]
   861   C2825407:Half [Quantitative Concept]

Phrase: "the death process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "observed at 0.5 mM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0444499:0/5 [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
Processing 00000000.tx.152: Characterization of the apoptotic population Next we wished to determine whether the death process caused by fatty acids corresponds to apoptosis or necrosis mechanisms. 

Phrase: "Characterization of the apoptotic population Next"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "we"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the death process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "caused by fatty acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   737   C0015127:cause [Functional Concept]
   737 E C0202406:Acid [Laboratory Procedure]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "corresponds to apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "or"

Phrase: "necrosis mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.153: The formation of a DNA ladder is indicative of apoptotic events (24, 25). 

Phrase: "The formation of a DNA ladder"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1817262:DNA formation [Genetic Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "indicative of apoptotic events"

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.154: Figure 3 shows that a DNA ladder occurred mainly in cells incubated in the presence of palmitate and oleate as well as with staurosporine. 

Phrase: "Figure 3"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that a DNA ladder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336762:Ladder [Manufactured Object]
   734   C0000702:A-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "mainly in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of palmitate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030233:palmitate [Lipid]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "as well as with staurosporine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
Processing 00000000.tx.155: DNA laddering was much less apparent in cells incubated in the absence of serum at 5 or 25 mM glucose only. 

Phrase: "DNA laddering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336762:laddering [Manufactured Object]

Phrase: "was"

Phrase: "much less apparent in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]

Phrase: "incubated in the absence of serum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0229671:Serum [Body Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "at 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "25 mM glucose only."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.156: No ladder was observed in cells incubated with the basal glucose level in the presence of FCS. 

Phrase: "No ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336762:Ladder [Manufactured Object]

Phrase: "was"

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with the basal glucose level"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0337438:glucose level [Laboratory Procedure]
   790   C0428548:Glucose level [Laboratory or Test Result]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0205112:Basal [Spatial Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.157: View larger version (108K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(108K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.158: Oleate and palmitate increase DNA fragmentation in serum-starved INS-1 cells. 

Phrase: "Oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "palmitate increase DNA fragmentation in serum-starved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0376669:DNA Fragmentation [Molecular Function]
   748   C0332472:Fragmentation [Anatomical Abnormality]
   748   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.159: DNA ladder analysis was carried out in extracts of INS-1 cells cultured for 36 h in the presence of 5 mM glucose plus 10% FCS (G5/FCS) or in medium containing 0.5% defatted BSA with in 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose plus 0.5 mM oleate; 

Phrase: "DNA ladder analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0200898:DNA analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in extracts of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   737   C2828366:Extract [Substance]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured for 36 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "in medium containing 0.5% defatted BSA with"

Phrase: "in 5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose plus 0.5 mM oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0133788:oleate [Lipid]
   793   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.160: 0.5 mM palmitate (Palm); 

Phrase: "0.5 mM palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.161: and 0.2 M staurosporine (Stauro). 

Phrase: "and"

Phrase: "0.2 M staurosporine (Stauro)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.162: DNA was extracted, and 10 g were resolved in a 1.5% agarose gel. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: ","

Phrase: "and"

Phrase: "10 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "resolved in a 1.5% agarose gel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1706746:Agarose Gel [Research Device]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.163: DNA markers are a /HindIII digest (left) and a 100-bp DNA ladder (right). 

Phrase: "DNA markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012872:Markers, DNA [Nucleotide Sequence]
   827   C0005516:Marker [Clinical Attribute]

Phrase: "are"

Phrase: "a /HindIII"

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a 100-bp DNA ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0336762:Ladder [Manufactured Object]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.164: The gel shown is representative of three independent experiments.  

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.165: Cells tended to detach from the culture dishes after 36 h when incubated in the absence of serum, and detachment markedly increased when either fatty acids or staurosporine were present. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "tended to"

Phrase: "detach from the culture dishes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0687118:detach [Functional Concept]
   760   C2242979:Culture [Laboratory Procedure]
   726   C0020498:DISH [Disease or Syndrome]

Phrase: "after 36 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "when"

Phrase: "incubated in the absence of serum,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0229671:Serum [Body Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "detachment markedly"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0541879:detachment [Mental Process]
   861   C0595950:Detachment [Pathologic Function]
   789 E C0687118:Detached [Functional Concept]
   789 E C1561504:detached [Idea or Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "either fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.166: Cells tended also to shrink and round up in the presence of fatty acids, displaying a high nucleus/cytoplasm ratio and a typical morphology (Fig. 4A) of apoptotic cells (24, 25). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "tended"

Phrase: "also to"

Phrase: "shrink"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205230:shrink [Spatial Concept]

Phrase: "and"

Phrase: "round up in the presence of fatty acids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332490:Round [Spatial Concept]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a high nucleus/cytoplasm ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "a typical morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "of apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.167: The mean percentages  SEM of cells displaying an apoptotic and/or necrotic phenotype were 2.5  0.1 [5 mM glucose (G5)/FCS], 10.4  0.5 (G5), 12.0  0.9 (G25), 45.4  5.4 (oleate; P < 0.001 vs. G5), 27.1  2.8 (palmitate; P < 0.001 vs. G5), and 65.2  6.2 (staurosporine; P < 0.001 vs. G5; n = 6). 

Phrase: "The mean percentages  SEM of cells"

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]

Phrase: "and/or"

Phrase: "necrotic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "were"

Phrase: "2.5  0.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0450346:2 5 [Quantitative Concept]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "[5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: "/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "],"

Phrase: "10.4  0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444499:0/5 [Quantitative Concept]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "12.0  0.9"

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "45.4  5.4"

Phrase: "(oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "27.1  2.8"

Phrase: "(palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "65.2  6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450385:65 [Intellectual Product]

Phrase: "(staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: "; n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.168: The number of cells presenting these phenotypic changes fits with the percentage of subdiploid cells determined by FACS analysis. 

Phrase: "The number of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "these phenotypic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "fits with the percentage of subdiploid cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0007634:Cells [Cell]
   748   C0036572:Fit [Sign or Symptom]
   748   C0424576:Fit [Finding]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C2349186:Fit [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "determined by FACS analysis."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   853   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   778   C0007616:Cell Sorting [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0237886:Sorting [Mental Process]
   748   C0700314:sorting [Cell Function]
   748   C0936012:Analysis [Research Activity]
   748   C1269647:Cell [Cell]
   748   C1524024:analysis [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1879547:Activated [Activity]
   748   C1947906:Sorting [Activity]
   748   C1948049:Cell [Spatial Concept]
   714 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.169: In addition, palmitate and oleate caused chromatin condensation, as revealed by the positive staining with Hoechst dye (Fig. 4B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate caused chromatin condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0233656:Condensation [Mental or Behavioral Dysfunction]
   812   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "as"

Phrase: "revealed by the positive staining"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0439178:% Positive [Quantitative Concept]
   760   C0443289:Revealed [Qualitative Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1704680:Staining [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "with Hoechst dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: These DNA and chromatin alterations were accompanied by an increase in PARP cleavage (data not shown) in cells treated with oleate, palmitate, and staurosporine. 

Phrase: "These DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "chromatin alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "accompanied by an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in PARP cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with oleate,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0133788:oleate [Lipid]
   790   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "palmitate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "staurosporine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.171: Therefore, these phenotypic changes observed in the presence of fatty acids correspond to the induction of an apoptotic process. 

Phrase: "Therefore,"

Phrase: "these phenotypic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "observed in the presence of fatty acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0015684:Fatty Acids [Lipid]
   748   C0001128:Acids [Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1441672:Observed [Functional Concept]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "correspond to the induction of an apoptotic process."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0162638:Apoptotic Process [Cell Function]
   769   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   744   C0205263:Induction [Functional Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C1184743:Process [Body Part, Organ, or Organ Component]
   744   C1516044:Apoptotic [Qualitative Concept]
   744   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.172: View larger version (160K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(160K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.173: A, Morphological analysis of INS cells cultured in the presence of various test substances. 

Phrase: "A,"

Phrase: "Morphological analysis of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in the presence of various test substances."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0392366:test [Intellectual Product]
   744   C0439861:Substances [Substance]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.174: INS cells were cultured for 36 h with 5 mM glucose plus 10% FCS (G5/FCS) or with medium containing 0.5% defatted BSA in the presence of 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose plus 0.5 mM oleate, 0.5 mM palmitate (Palm), and 0.2 M staurosporine (Stauro). 

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 36 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "with 5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "or with medium containing 0.5% defatted BSA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0444499:0/5 [Quantitative Concept]
   744   C0009458:Medium [Intellectual Product]
   744   C0332256:Containing [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C2700400:Containing [Activity]
   744   C3244283:medium [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose plus 0.5 mM oleate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0133788:oleate [Lipid]
   793   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "0.5 mM palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.2 M staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(Stauro"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.175: Images of representative fields are captured at a magnification of x40. 

Phrase: "Images of representative fields"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "captured at a magnification of x40."
Processing 00000000.tx.176: Bars, 12 m. 

Phrase: "Bars,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "12 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.177: B, Chromatin condensation analysis of INS cells determined by Hoechst 33342 staining. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chromatin condensation analysis of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "determined by Hoechst 33342 staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0062907:Hoechst 33342 [Pharmacologic Substance]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.178: Cells were grown on poly-L-lysine-treated glass slides and incubated under the same conditions as described in A. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on poly-L-lysine-treated glass slides"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0017596:Glass [Manufactured Object]
   744   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0444330:slides [Research Device]
   744   C0747726:POLY [Conceptual Entity]
   744   C1522326:Treated [Functional Concept]
   744   C1947936:Glass [Medical Device]
   711 E C1292734:TREAT [Functional Concept]
   711 E C1705201:Slide [Manufactured Object]

Phrase: "and"

Phrase: "incubated under the same conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0445247:Same [Qualitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.179: Figures are representative of three independent experiments. 

Phrase: "Figures"

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.180: Images are captured at x40. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "captured at x40."
Processing 00000000.tx.181: Bars, 12 m. 

Phrase: "Bars,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "12 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.182: *, Representative staining of mitosis; 

Phrase: "*,"

Phrase: "Representative staining of mitosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: ";"
Processing 00000000.tx.183: arrow, representative staining of condensed chromatin.  

Phrase: "arrow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "representative staining of condensed chromatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.184: View larger version (87K): [in this window] [in a new window]  Figure 4A. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(87K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "Figure"

Phrase: "4A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]
Processing 00000000.tx.185: Continued.  

Phrase: "Continued."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]
Processing 00000000.tx.186: Mechanisms of the apoptotic process induced by fatty acids Previous studies in several cellular models documented that altered mitochondria function plays a prominent role in the induction of apoptosis under serum-starved conditions (14, 26, 27, 28, 29). 

Phrase: "Mechanisms of the apoptotic process"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "induced by fatty acids Previous studies"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0015684:Fatty Acids [Lipid]
   753   C0001128:Acids [Chemical]
   753   C0205156:Previous [Temporal Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1552607:previous [Temporal Concept]
   719 E C0202406:Acid [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "in several cellular models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "that altered mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a prominent role in the induction of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "under serum-starved conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(14,"

Phrase: "26,"

Phrase: "27,"

Phrase: "28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.187: Mitochondria dysfunction can be assessed by several parameters, including superoxide production, loss of mitochondria membrane potential, cytochrome c, and AIF release. 

Phrase: "Mitochondria dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "assessed by several parameters,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0449381:Parameters [Finding]
   770   C1516048:Assessed [Activity]
   737 E C0549193:Parameter [Spatial Concept]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "superoxide production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "loss of mitochondria membrane potential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "AIF release."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
Processing 00000000.tx.188: Disruption of the membrane-associated electron transport chain leads to incomplete reduction of O2 and production of reactive oxygen species, such as the superoxide radical. 

Phrase: "Disruption of the membrane-associated electron transport chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332453:Disruption [Functional Concept]

Phrase: "leads to incomplete reduction of O2"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0181586:leads [Medical Device]
   753   C0205257:Incomplete [Quantitative Concept]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C0728938:incomplete [Quantitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1548386:incomplete [Idea or Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "production of reactive oxygen species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "such as the superoxide radical."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0038836:Superoxide Radical [Element, Ion, or Isotope]
           Superoxide
   861   C0302912:Radical [Chemical Viewed Structurally]
   861   C0439807:Radical [Qualitative Concept]
Processing 00000000.tx.189: Serum removal considerably increased superoxide production, and oleate and palmitate caused a further rise in O2- production by (INS)-cells (Fig. 5A; P < 0.05 vs. cells incubated with 5 mM glucose in the presence of BSA). 

Phrase: "Serum removal considerably increased superoxide production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a further rise in O2- production"

Phrase: "by"

Phrase: "("

Phrase: "INS)-cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with 5 mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of BSA"

Phrase: ")."
Processing 00000000.tx.190: View larger version (29K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.191: Effect of serum starvation and elevated glucose and fatty acids on superoxide production and the mitochondrial membrane potential (m) of INS-1 cells. 

Phrase: "Effect of serum starvation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "elevated glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "fatty acids on superoxide production"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0015684:Fatty Acids [Lipid]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "the mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "("

Phrase: "m) of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0441923:M+ [Intellectual Product]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.192: A, INS cells were cultured for 36 h in the presence of 5 mM glucose plus 10% FCS (G5/FCS) and 0.5% defatted BSA at 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose plus 0.5 mM oleate (Ol), 0.5 mM palmitate (Palm), and 0.2 M staurosporine (Stauro). 

Phrase: "A,"

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 36 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "0.5% defatted BSA at 5 mM glucose"

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose plus 0.5 mM oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0133788:oleate [Lipid]
   793   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Ol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "0.5 mM palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.2 M staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(Stauro"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.193: Cells were then detached from the flasks and incubated in suspension at room temperature with 1 g/ml dihydroethidine for 2 min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "detached from the flasks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0687118:Detached [Functional Concept]
   770   C0872171:flasks [Medical Device]
   770   C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "incubated in suspension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0038960:Suspension [Biomedical or Dental Material]
   790   C1382107:Suspension [Substance]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1705537:Suspension [Functional Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with 1 g/ml dihydroethidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1741836:dihydroethidine [Organic Chemical]

Phrase: "for 2 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.194: Superoxide production was determined by the change in fluorescence from blue to red in an EPICS flow cytometer. 

Phrase: "Superoxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "determined by the change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "from blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "to red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "in an EPICS flow cytometer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0180279:Flow Cytometer [Medical Device]
   827   C0806140:Flow [Natural Phenomenon or Process]
Processing 00000000.tx.195: B, For m determinations cells were harvested after 36-h culture and incubated in suspension at room temperature with 10 g/ml rhodamine 123 for 5 min. m was assessed through rhodamine fluorescence measurements, determined in an EPICS cytometer. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "For m determinations cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0599757:M-cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested after 36-h culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0010453:Culture [Idea or Concept]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0220814:culture [Functional Concept]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C2242979:Culture [Laboratory Procedure]
   726   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "incubated in suspension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0038960:Suspension [Biomedical or Dental Material]
   790   C1382107:Suspension [Substance]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1705537:Suspension [Functional Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with 10 g/ml rhodamine 123"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for 5 min. m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "assessed through rhodamine fluorescence measurements,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0242485:measurements [Functional Concept]
   760   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1516048:Assessed [Activity]

Phrase: "determined in an EPICS cytometer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1273342:EPIC [Laboratory Procedure]
Processing 00000000.tx.196: Values shown are the mean  SEM of four independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of four independent experiments."
Processing 00000000.tx.197: *, P < 0.05 vs. 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.198: G5/BSA.  

Phrase: "G5/BSA."
Processing 00000000.tx.199: Consistent with the O2- measurements, serum removal caused a pronounced reduction of the mitochondrial membrane potential, as evaluated using rhodamine 123 (Fig. 5B). 

Phrase: "Consistent with the O2- measurements,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "serum removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015252:Removal [Therapeutic or Preventive Procedure]
   861   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a pronounced reduction of the mitochondrial membrane potential,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   848   C2612224:reduction of mitochondrial membrane potential [Cell Function]
   819   C1156295:reduction of membrane potential [Cell Function]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rhodamine 123"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.200: Both fatty acids had only a minor additive effect on the top of the serum removal condition (P < 0.05 vs. the G5/BSA condition). 

Phrase: "Both fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "had"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor additive effect on the top of the serum removal condition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0442796:Additive [Qualitative Concept]
   736   C1280500:Effect [Qualitative Concept]
   736   C1550602:Additive [Substance]
   736   C2348382:Effect [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."

Phrase: "the G5/BSA condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   727 E C1519605:Conditionality [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.201: The release of different proteins from mitochondria is implicated in the late stages of the apoptotic process (24, 27). 

Phrase: "The release of different proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "is"

Phrase: "implicated in the late stages of the apoptotic process"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0162638:Apoptotic Process [Cell Function]
   764   C1279941:late stages [Temporal Concept]
   742   C0205087:Late [Temporal Concept]
   742   C1184743:Process [Body Part, Organ, or Organ Component]
   742   C1306673:Stages [Qualitative Concept]
   742   C1516044:Apoptotic [Qualitative Concept]
   742   C1522240:Process [Phenomenon or Process]
   708 E C0205390:Stage [Temporal Concept]
   708 E C1300072:Stage [Clinical Attribute]

Phrase: "(24,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.202: Therefore, we determined whether cytochrome c, AIF, and caspase-2 relocate from the mitochondrial compartment to the cytosol in INS-1 cells exposed to fatty acids. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "AIF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "caspase-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "relocate from the mitochondrial compartment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "to the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to fatty acids."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0015684:Fatty Acids [Lipid]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0001128:Acids [Chemical]
   737 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.203: Figure 6 shows that no measurable release of cytochrome c and AIF was observed when cells were incubated with 5 mM glucose in the absence or presence of FCS. 

Phrase: "Figure 6"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "no measurable release of cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "AIF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with 5 mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of FCS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.204: High glucose caused a modest release of cytochrome c. 

Phrase: "High glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a modest release of cytochrome c."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.205: However, both palmitate and mainly oleate induced a prominent release of cytochrome c and AIF to the cytosol similar to that observed with staurosporine. 

Phrase: "However,"

Phrase: "both palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "mainly oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0133788:oleate [Lipid]
   861   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a prominent release of cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "AIF to the cytosol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   753   C0162638:Apoptosis [Cell Function]
   753   C0205263:Inducing [Functional Concept]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed with staurosporine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.206: The release of cytochrome c in the presence of oleate (Fig. 7) and palmitate (not shown) was gradual over time, reaching a maximum after 3036 h of incubation. 

Phrase: "The release of cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "gradual over time,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439833:Gradual [Qualitative Concept]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "a maximum after 3036 h of incubation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2946875:Maximum-H [Pharmacologic Substance]
   748   C0806909:Maximum [Quantitative Concept]
   748   C1552615:maximum [Quantitative Concept]
   748   C2826546:MAXIMUM [Quantitative Concept]
Processing 00000000.tx.207: On the other hand, AIF translocation from mitochondria in the presence of palmitate (not shown) and oleate (Fig. 7) was delayed with respect to that of cytochrome c, and the protein started to be detected in the cytosolic fraction only after 3036 h of incubation. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "AIF translocation from mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C2987521:Translocation [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "was"

Phrase: "delayed with respect to that of cytochrome c,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   770   C1153524:cytochrome c [Molecular Function]
   770   C1426584:CYTOCHROME C [Gene or Genome]
   744   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205421:Delayed [Temporal Concept]
   744   C0679133:respect [Social Behavior]
   744   C1325304:cytochrome [Molecular Function]
   744   C3272602:Delayed [Qualitative Concept]

Phrase: "and"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "detected in the cytosolic fraction only"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205171:Only [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1383501:Cytosolic [Cell Component]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1554103:Fraction [Idea or Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "after 3036 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation."
Processing 00000000.tx.208: View larger version (9K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.209: Elevated fatty acids promote cytochrome c and AIF release in INS-1 cells. 

Phrase: "Elevated fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "AIF release in"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.210: Cytosolic fractions were obtained from treated cells after 36-h incubation as described in Materials and Methods. 

Phrase: "Cytosolic fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "obtained from treated cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1301820:Obtained [Functional Concept]
   770   C1522326:Treated [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1292734:TREAT [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "after 36-h incubation"

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.211: Aliquots of 20 g protein were resolved on a 12.5% SDS-polyacrylamide gel, blotted, and revealed by a monoclonal cytochrome c antibody or an AIF polyclonal antibody. 

Phrase: "Aliquots of 20 g protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on a 12.5% SDS-polyacrylamide gel,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C1382104:Gel [Substance]
   744   C1514893:Resolved [Idea or Concept]
   744   C2699488:Resolved [Conceptual Entity]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "revealed by a monoclonal cytochrome c antibody"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   778   C1153524:cytochrome c [Molecular Function]
   778   C1426584:CYTOCHROME C [Gene or Genome]
   774   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0443289:Revealed [Qualitative Concept]
   748   C0746619:monoclonal [Finding]
   748   C1325304:cytochrome [Molecular Function]

Phrase: "or"

Phrase: "an AIF polyclonal antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
Processing 00000000.tx.212: Experimental conditions were 5 mM glucose plus 10% FCS (G5/FCS), and 0.5% defatted BSA at 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose with 0.5 mM palmitate (Palm), 0.5 mM oleate (Ol), and 0.2 M staurosporine (St). 

Phrase: "Experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.5% defatted BSA at 5 mM glucose"

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose with 0.5 mM palmitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")"

Phrase: ","

Phrase: "0.5 mM oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0133788:oleate [Lipid]
   812   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Ol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.2 M staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(St"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.213: Ct, Purified cytochrome c control from bovine heart and Jurkat whole cell lysate control for AIF. 

Phrase: "Ct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "Purified cytochrome c control from bovine heart"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Jurkat whole cell lysate control for AIF."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0683951:control factor [Quantitative Concept]
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.214: The immunoblots shown are representative of four independent experiments.  

Phrase: "The immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of four independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.215: View larger version (31K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.216: Time course of cytochrome c and AIF release from mitochondria and cytosolic caspase-2 accumulation in INS-1 cells incubated in the presence of oleate. 

Phrase: "Time course of cytochrome c"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0449247:Time course [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0750729:Course [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "AIF release from mitochondria"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cytosolic caspase-2 accumulation in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of oleate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0133788:oleate [Lipid]
   753   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.217: Cells were cultured for the indicated times in the presence of 0.5 mM oleate. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for the indicated times"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0040223:times [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.5 mM oleate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0133788:oleate [Lipid]
   812   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
Processing 00000000.tx.218: Subcellular fractionation was performed as described in Materials and Methods. 

Phrase: "Subcellular fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.219: Aliquots of 15 g protein for the cytosolic (CYT) fraction and 10 g protein for the particulate (PART) fraction were resolved on 12.5% SDS-polyacrylamide gels, blotted, and revealed using cytochrome c, AIF, and caspase-2 antibodies. 

Phrase: "Aliquots of 15 g protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "for the cytosolic (CYT) fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "10 g protein for the particulate (PART) fraction"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   774 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on 12.5% SDS-polyacrylamide gels,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]
   714 E C1382104:Gel [Substance]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "AIF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "caspase-2 antibodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C1320096:Caspase antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.220: The immunoblots shown are representative of three independent experiments.  

Phrase: "The immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.221: Caspase-2 is an important zymogen distributed in cytosol and mitochondria. 

Phrase: "Caspase-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an important zymogen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014436:zymogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   768 E C0015852:Fermentation [Molecular Function]

Phrase: "distributed in cytosol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1383501:Cytosol [Cell Component]
   790   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.222: After specific stresses, mitochondrial caspase-2 as well as cytochrome c and AIF can be released from mitochondria to the cytosol, thus triggering apoptosis (30). 

Phrase: "After specific stresses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0038435:Stress [Finding]
   777 E C0231297:Stressful [Functional Concept]

Phrase: "mitochondrial caspase-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "as well as"

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "AIF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "released from mitochondria"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0026237:Mitochondria [Cell Component]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "to the cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "thus"

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.223: Caspase-2 activation has been implicated in the induction of apoptosis by GTP depletion in HIT-T15 cells (31). 

Phrase: "Caspase-2 activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the induction of apoptosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   753   C0162638:Apoptosis [Cell Function]
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by GTP depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "in HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.224: In contrast to cytochrome c and AIF, caspase-2 was not apparently redistributed from mitochondria to cytosol when cells were incubated in the presence of fatty acids (Fig. 7). 

Phrase: "In contrast to cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "AIF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "caspase-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "not apparently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750541:apparently [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "redistributed from mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026237:Mitochondria [Cell Component]

Phrase: "to cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the presence of fatty acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0015684:Fatty Acids [Lipid]
   748   C0001128:Acids [Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1439852:Incubated [Laboratory Procedure]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.225: However, the amount of caspase-2 increased in the cytosolic fraction of cells incubated in the presence of oleate after a 30- to 36-h period (Fig. 7). 

Phrase: "However,"

Phrase: "the amount of caspase-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "increased in the cytosolic fraction of cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   757   C0805525:Cell Fraction [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1383501:Cytosolic [Cell Component]
   748   C1554103:Fraction [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of oleate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0133788:oleate [Lipid]
   753   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "after a 30-"

Phrase: "to 36-h period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.226: Similar results were observed with palmitate, although the effect was somewhat smaller. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed with palmitate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030233:palmitate [Lipid]
   790   C1441672:Observed [Functional Concept]
   790   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "although"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "somewhat smaller."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547044:Smaller [Qualitative Concept]
   861   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.227: It has been described in human (32) and rat islets (6) incubated in the presence of fatty acids that the progression to apoptosis is associated with reduced mRNA levels of the antiapoptotic protein Bcl-2, although the expression level of the Bcl-2 protein was not measured in one of these studies (32). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "described in human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Human [Human]
   790   C1552738:described [Idea or Concept]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "rat islets"

Phrase: "(6"

Phrase: ")"

Phrase: "incubated in the presence of fatty acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0015684:Fatty Acids [Lipid]
   748   C0001128:Acids [Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1439852:Incubated [Laboratory Procedure]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "the progression to apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "is"

Phrase: "associated with reduced mRNA levels of the antiapoptotic protein Bcl-2,"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   772   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   756   C0376515:Bcl-2 [Gene or Genome]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0392756:Reduced [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C2986514:antiapoptotic [Chemical Viewed Functionally]
   737   C0428479:Protein level [Laboratory or Test Result]
   737   C0456948:Level 2 [Intellectual Product]
   704 E C0456079:Level [Classification]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1547707:Level [Geographic Area]
   704 E C1706221:Associate [Professional or Occupational Group]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "although"

Phrase: "the expression level of the Bcl-2 protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C3244092:expression level [Idea or Concept]
   767   C0428479:Protein level [Laboratory or Test Result]
   767   C0456948:Level 2 [Intellectual Product]
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "measured in one of these studies"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0205447:One [Quantitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.228: Immunoblot analysis revealed that the amount of the Bcl-2 protein remained relatively stable over a 36-h period in the presence of elevated glucose or fatty acids, decreasing only in staurosporine-treated cells (Fig. 8). 

Phrase: "Immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the amount of the Bcl-2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "remained"

Phrase: "relatively stable over a 36-h period"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stable [Qualitative Concept]
   748   C1547311:Stable [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of elevated glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "only in staurosporine-treated cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   760   C0205171:Only [Quantitative Concept]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C1720467:Only [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.229: Similar observations were made at 60 h (not shown). 

Phrase: "Similar observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "were"

Phrase: "made at 60 h ("
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C1881534:Make [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.230: However, the proapoptotic protein Bax increased in cells incubated in the presence of oleate and to a lesser degree with palmitate (Fig. 8). 

Phrase: "However,"

Phrase: "the proapoptotic protein Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0812198:BAX [Gene or Genome]

Phrase: "increased in cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "incubated in the presence of oleate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0133788:oleate [Lipid]
   753   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "and to a lesser degree"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C0547044:Lesser [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "with palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.231: View larger version (20K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.232: Elevated fatty acids do not affect Bcl-2 levels, but induce Bax accumulation in INS-1 cells. 

Phrase: "Elevated fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Bcl-2 levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0376515:Bcl-2 [Gene or Genome]

Phrase: "but"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Bax accumulation in"

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.233: Cellular extracts were obtained at 36 h from treated cells as described in Materials and Methods. 

Phrase: "Cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained at 36 h"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "from treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.234: Aliquots of 20 g protein were resolved on 12.5% SDS-polyacrylamide gel, blotted, and revealed by Bcl-2 or Bax polyclonal antibodies. 

Phrase: "Aliquots of 20 g protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on 12.5% SDS-polyacrylamide gel,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "revealed by Bcl-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0376515:Bcl-2 [Gene or Genome]
   770   C0443289:Revealed [Qualitative Concept]

Phrase: "or"

Phrase: "Bax polyclonal antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.235: Experimental conditions were 5 mM glucose plus 10% FCS (G5/FCS), and 0.5% defatted BSA at 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose with 0.5 mM palmitate (Palm), 0.5 mM oleate (Ol), and 0.2 M staurosporine (St). 

Phrase: "Experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.5% defatted BSA at 5 mM glucose"

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose with 0.5 mM palmitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")"

Phrase: ","

Phrase: "0.5 mM oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0133788:oleate [Lipid]
   812   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Ol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.2 M staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(St"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.236: The immunoblots shown are representative of three independent experiments.  

Phrase: "The immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.237: Several studies have provided evidence that NO production is involved in the apoptotic death of pancreatic -cells induced by cytokines (1, 2) and possibly fatty acids as well, via iNOS induction (4). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "involved in the apoptotic death of pancreatic -cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0162638:apoptotic cell death [Cell Function]
   767   C0007587:cells death [Cell Function]
   744   C0007634:Cells [Cell]
   744   C0011065:Death [Organism Function]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C1306577:Death, NOS [Finding]
   744   C1314939:Involved [Functional Concept]
   744   C1516044:Apoptotic [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "induced by cytokines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0205263:Induced [Functional Concept]
   790   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "possibly fatty acids as well,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0015684:Fatty Acids [Lipid]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "via iNOS induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]
   756   C0669372:Inducible NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.238: Oleate increased NO production (P < 0.05 vs. cells incubated in the presence of 5 mM glucose/BSA), further indicating that it causes oxidative stress (Fig. 9A). 

Phrase: "Oleate increased NO production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033268:production [Occupational Activity]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of 5 mM glucose/BSA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1439852:Incubated [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "it"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.239: Palmitate had a modest, but significant, effect on NO production (P < 0.05 vs. G5/BSA condition). 

Phrase: "Palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "had"

Phrase: "a modest,"

Phrase: "but"

Phrase: "significant, effect on NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. G5/BSA condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   727 E C1519605:Conditionality [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.240: We also measured the expression level of iNOS. 

Phrase: "We also"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the expression level of iNOS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.241: A mixture of three cytokines (IL-1, IFN, and TNF), known to be efficient in inducing iNOS gene in this cell type (33), was used as a positive control. 

Phrase: "A mixture of three cytokines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "(IL-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "IFN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "TNF"

Phrase: ")"

Phrase: ","

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "efficient in inducing iNOS gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442799:Efficient [Qualitative Concept]

Phrase: "in this cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "used as a positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.242: The results shown in Fig. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.243: 9B indicate that the expression level of iNOS under basal conditions was below the detection limit of the Western blot and that fatty acids did not appear to induce iNOS. 

Phrase: "9B"

Phrase: "indicate"

Phrase: "that"

Phrase: "the expression level of iNOS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "under basal conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was below the detection limit of the Western blot"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   784   C2718050:Limit of Detection [Quantitative Concept]
           Detection Limit
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0949466:Western Blot [Laboratory Procedure]
   742   C0043194:WAS [Disease or Syndrome]
   742   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439801:limit [Functional Concept]
   742   C1421478:WAS [Gene or Genome]
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
   742   C1549649:Limit [Idea or Concept]
   742   C1705493:Western [Spatial Concept]
   742   C2349209:Limit [Conceptual Entity]

Phrase: "and"

Phrase: "that fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "iNOS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0669372:Inducible NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0132555:NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
Processing 00000000.tx.244: View larger version (33K): [in this window] [in a new window]  Figure 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 9."
Processing 00000000.tx.245: Effect of various experimental conditions on NO production and iNOS protein expression level in INS cells. 

Phrase: "Effect of various experimental conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "iNOS protein expression level in"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1171362:protein expression [Genetic Function]
   778   C3244092:expression level [Idea or Concept]
   774   C0428479:Protein level [Laboratory or Test Result]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "INS cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.246: A, Cells were cultured for 36 h in the presence of 5 mM glucose plus 10% FCS (G5/FCS) in the presence or absence of cytokines (IL-1, TNF, and IFN), and 0.5% defatted BSA at 5 mM glucose (G5), 25 mM glucose (G25), or 5 mM glucose plus 0.5 mM palmitate (Palm) and 0.5 mM oleate (Ol). 

Phrase: "A,"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 36 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of cytokines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(IL-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "TNF,"

Phrase: "and"

Phrase: "IFN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.5% defatted BSA at 5 mM glucose"

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5 mM glucose plus 0.5 mM palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0030233:palmitate [Lipid]
   793   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "0.5 mM oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0133788:oleate [Lipid]
   812   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Ol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.247: NO was determined as nitrite as indicated in Materials and Methods. 

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "determined as nitrite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028137:Nitrite [Chemical Viewed Structurally]
   790   C1384115:Nitrite [Inorganic Chemical]

Phrase: "as"

Phrase: "indicated in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.248: Values shown are the mean  SEM of three independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the mean  SEM of three independent experiments."
Processing 00000000.tx.249: *, P < 0.05 vs. 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.250: G5/BSA. 

Phrase: "G5/BSA."
Processing 00000000.tx.251: B, Cells were incubated for 24 h in the presence of different test substances. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of different test substances."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substances [Substance]
Processing 00000000.tx.252: Aliquots of 25 g protein were resolved on 7.5% SDS-polyacrylamide gels, blotted, and revealed using an iNOS polyclonal antibody. 

Phrase: "Aliquots of 25 g protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on 7.5% SDS-polyacrylamide gels,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]
   714 E C1382104:Gel [Substance]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an iNOS polyclonal antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0669372:Inducible NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.253: The immunoblot shown is representative of three independent experiments. 

Phrase: "The immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.254: Conditions were 5 mM glucose plus 10% FCS (G5/FCS), 0.5% defatted BSA with 5 mM glucose (G5), 25 mM glucose (G25), 0.5 mM palmitate (Palm), 0.5 mM oleate (Ol), 0.2 M staurosporine (St), and 5 mM glucose, 10% FCS, and cytokines (IL-1 + IFN + TNF-). 

Phrase: "Conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "5 mM glucose plus 10% FCS"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C0202041:glucose serum [Laboratory Procedure]
   864   C3534430:Glucose.serum [Laboratory or Test Result]
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(G5/FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "0.5% defatted BSA with 5 mM glucose"

Phrase: "(G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G25"

Phrase: ")"

Phrase: ","

Phrase: "0.5 mM palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Palm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: ")"

Phrase: ","

Phrase: "0.5 mM oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0133788:oleate [Lipid]
   812   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(Ol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "0.2 M staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(St"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "5 mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "10% FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(IL-1 + IFN + TNF-"

Phrase: ")."
Processing 00000000.tx.255: Ct, Activated macrophage cell extract.   

Phrase: "Ct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "Activated macrophage cell extract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2828366:Extract [Substance]
Processing 00000000.tx.256: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Elevated circulating fatty acids, such as occurs during fasting or the early stages of obesity, are not very toxic to the -cell because the -cell is expected to adapt via the induction of genes of the fat oxidation pathways, resulting in fat oxidation and lipid detoxification (13). 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "such as"

Phrase: "occurs during fasting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0015663:Fasting [Finding]
   790   C1550565:fasting [Intellectual Product]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   756 E C0456962:Fast [Qualitative Concept]

Phrase: "or"

Phrase: "the early stages of obesity,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C2363430:early stages [Temporal Concept]
   790 E C1517886:Early Stage [Classification]
   760   C1306673:Stages [Qualitative Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]

Phrase: "are"

Phrase: "not very toxic to the -cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]

Phrase: "because"

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adapt via the induction of genes of the fat oxidation pathways,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   738   C0017337:Genes [Gene or Genome]
   738   C0030011:Oxidation [Molecular Function]
   738   C0205263:Induction [Functional Concept]
   738   C0424612:FAT [Organism Attribute]
   738   C0857127:induction [Therapeutic or Preventive Procedure]
   738   C1704259:Pathways [Molecular Function]
   738   C1705987:Pathways [Conceptual Entity]
   738   C2937289:adapt [Organic Chemical]
   737   C0812278:FAT Gene [Gene or Genome]
   737   C0920532:gene induction [Genetic Function]

Phrase: "resulting in fat oxidation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0030011:Oxidation [Molecular Function]
   770   C0424612:FAT [Organism Attribute]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "lipid detoxification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025516:Detoxification [Organism Function]
   861   C0150543:Detoxification [Therapeutic or Preventive Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.257: However, it can be hypothesized that under conditions where the -cell is stressed, such as high glucose, islet inflammation, and cytokine production by lymphocytes or oxidative stress, elevated fatty acids may become very toxic to the -cell because they cannot be efficiently detoxified. 

Phrase: "However,"

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "hypothesized"

Phrase: "that under conditions where"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "stressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038435:stressed [Finding]

Phrase: ","

Phrase: "such as high glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "islet inflammation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "cytokine production by lymphocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1327413:cytokine production [Organism Function]
   802   C0302097:Lymphocyte production [Organ or Tissue Function]
   770   C0033268:production [Occupational Activity]

Phrase: "or"

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "become"

Phrase: "very toxic to the -cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0600688:toxic [Injury or Poisoning]
   760   C1407029:Toxic [Qualitative Concept]

Phrase: "because"

Phrase: "they"

Phrase: "cannot"

Phrase: "be"

Phrase: "efficiently"

Phrase: "detoxified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0025516:detoxify [Organism Function]
Processing 00000000.tx.258: With this background in mind we used serum removal as a model of stressed -cell and studied the action of fatty acids under this condition. 

Phrase: "With this background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "in mind"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0229992:Mind, NOS [Mental Process]
   944 E C0229993:Psychic [Functional Concept]
   916 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   916 E C0042241:DIAPHRAGM [Medical Device]
   916 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   916 E C1705367:Diaphragm [Medical Device]
   900 E C0086045:mindfulness [Mental Process]
   900 E C3542996:Mindfulness [Mental Process]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "serum removal as a model of stressed -cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015252:Removal [Therapeutic or Preventive Procedure]
   744   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the action of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "under this condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.259: Interestingly, we found that serum removal causes oxidative stress and impairs (INS-1)-cell mitochondrial function. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that serum removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015252:Removal [Therapeutic or Preventive Procedure]
   861   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "impairs"

Phrase: "("

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "cell mitochondrial function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C0007613:Cell Function [Cell Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.260: In this respect it is established that the -cell is particularly sensitive to oxidative stress, possibly because it contains low levels of oxygen radicals scavengers, such as superoxide dismutase, catalase, and glutathione peroxidase (34). 

Phrase: "In this respect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: "it"

Phrase: "is"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "particularly sensitive to oxidative stress,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "low levels of oxygen radicals scavengers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "such as superoxide dismutase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "glutathione peroxidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.261: The mitochondrial-dependent apoptotic process can be divided into three phases: initiation, progression, and execution (25, 26). 

Phrase: "The mitochondrial-dependent apoptotic process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0162638:Apoptotic Process [Cell Function]
   812   C1184743:Process [Body Part, Organ, or Organ Component]
   812   C1522240:Process [Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "divided into three phases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205449:Three [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0585064:Phases [Temporal Concept]
   770   C1067936:Phasis [Eukaryote]
   737 E C0205390:Phase [Temporal Concept]

Phrase: ":"

Phrase: "initiation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "progression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "execution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1278561:Execution [Governmental or Regulatory Activity]
  1000   C1705848:Execution [Activity]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.262: During the first phase, particular proapoptotic signals rise in the cell and act on mitochondria to alter the permeability of their membranes. 

Phrase: "During the first phase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "particular proapoptotic signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "rise in the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "act on mitochondria to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026237:Mitochondria [Cell Component]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the permeability of their membranes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0007605:membrane permeability [Cell Function]
   760   C0031164:Permeability [Natural Phenomenon or Process]
Processing 00000000.tx.263: Mitochondrial dysfunction can be monitored by several parameters, including overproduction of superoxide radical, as a result of respiratory chain failure, and loss of mitochondrial membrane potential (28). 

Phrase: "Mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "monitored by several parameters,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0449381:Parameters [Finding]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737 E C0549193:Parameter [Spatial Concept]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "overproduction of superoxide radical,"

Phrase: "as"

Phrase: "a result of respiratory chain failure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "and"

Phrase: "loss of mitochondrial membrane potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.264: During the progression phase, which in this study spans from approximately 1830 h, mitochondrial membrane permeabilization is achieved, allowing the gradual relocation of cytochrome c in the cytosolic compartment. 

Phrase: "During the progression phase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "which in this study spans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726   C1711300:Span [Conceptual Entity]
   726   C2700613:Span [Quantitative Concept]

Phrase: "from approximately 1830 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "mitochondrial membrane permeabilization"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C3158982:mitochondrial membrane permeabilization [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "achieved"

Phrase: ","

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "the gradual relocation of cytochrome c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699029:Relocation [Activity]

Phrase: "in the cytosolic compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.265: The final execution phase, coincident with the 30- to 36-h period of this study, culminates with the maximum release of cytochrome c and AIF from mitochondria, the induction of mitochondrial-destabilizing proapoptotic factors (i.e. Bax), and the activation of catabolic proteases (such as cytosolic caspase-2) and nucleases (such as PARP) that are responsible for the DNA ladder and chromatin pattern observed in the programmed cell death process (31, 35, 36, 37, 38). 

Phrase: "The final execution phase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205390:Phase [Temporal Concept]

Phrase: "coincident with the 30-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205420:Coincident [Temporal Concept]

Phrase: "to 36-h period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "of this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "culminates with the maximum release of cytochrome c"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   770   C1153524:cytochrome c [Molecular Function]
   770   C1426584:CYTOCHROME C [Gene or Genome]
   744   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C0806909:Maximum [Quantitative Concept]
   744   C1283071:Release [Functional Concept]
   744   C1325304:cytochrome [Molecular Function]
   744   C1552615:maximum [Quantitative Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]
   744   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "and"

Phrase: "AIF from mitochondria,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   760   C0162638:Apoptosis [Cell Function]
   760   C0205263:Inducing [Functional Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "the induction of mitochondrial-destabilizing proapoptotic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(i.e. Bax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0812198:BAX [Gene or Genome]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the activation of catabolic proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "("

Phrase: "such as cytosolic caspase-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1383501:Cytosolic [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "nucleases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597094:nucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "such as PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: ")"

Phrase: "that"

Phrase: "are"

Phrase: "responsible for the DNA ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "chromatin pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "observed in the programmed cell death process"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0007587:Cell Death Process [Cell Function]
           Cell Death
   814   C0162638:Programmed Cell Death [Cell Function]
   774   C0007613:Cell Process [Cell Function]
   774   C0230625:Cell process [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1184743:Process [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1441672:Observed [Functional Concept]
   748   C1522240:Process [Phenomenon or Process]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "35,"

Phrase: "36,"

Phrase: "37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.266: Taking into account this general knowledge of apoptosis, we conclude that serum deprivation predisposes INS-1 cells to enter into a preapoptotic stage. 

Phrase: "Taking into"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "this general knowledge of apoptosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376554:Knowledge [Intellectual Product]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that serum deprivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871712:Deprivation [Qualitative Concept]

Phrase: "predisposes INS-1 cells to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C1414685:INS-1 [Gene or Genome]
   806   C3538717:INS-1 [Gene or Genome]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "enter into a preapoptotic stage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   760   C1522196:ENTER [Functional Concept]
Processing 00000000.tx.267: This is supported by the fact that under these conditions mitochondria are severely affected in terms of free radical production and membrane potential decay, both considered early markers in the apoptotic process (26, 27, 28). 

Phrase: "This"

Phrase: "is"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that under these conditions mitochondria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026237:Mitochondria [Cell Component]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "are"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "affected in terms of free radical production"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   748   C0033268:production [Occupational Activity]
   748   C0302912:Radical [Chemical Viewed Structurally]
   748   C0332296:free [Functional Concept]
   748   C0392760:Affected [Functional Concept]
   748   C0439807:Radical [Qualitative Concept]
   748   C1314939:Affected [Functional Concept]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   714 E C0001721:Affect [Mental Process]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "membrane potential decay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1265875:Decay [Acquired Abnormality]
   827   C2700592:Decay [Phenomenon or Process]
   734   C0025251:Membrane Potential [Cell Function]

Phrase: "both considered early markers in the apoptotic process"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0005516:Marker [Clinical Attribute]

Phrase: "(26,"

Phrase: "27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.268: The low levels of subdiploid population in serum-free conditions as well as the undetectable amounts of cytochrome c and AIF release, condensed chromatin, and DNA laddering, are indicative that the progression to a further apoptotic stage was not accomplished, at least during the first 36 h of serum removal in the absence of fatty acids. 

Phrase: "The low levels of subdiploid population"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in serum-free conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "as well as"

Phrase: "the undetectable amounts of cytochrome c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "AIF release,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]

Phrase: "condensed chromatin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019397:Chromatin, condensed [Cell Component]
   861   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   861   C1325550:chromatin [Cell Component]

Phrase: "and"

Phrase: "DNA laddering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336762:laddering [Manufactured Object]

Phrase: "are"

Phrase: "indicative"

Phrase: "that"

Phrase: "the progression to a further apoptotic stage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accomplished"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "during the first 36 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "of serum removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015252:Removal [Therapeutic or Preventive Procedure]
   861   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of fatty acids."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.269: However, the apoptotic programs appear to be executed when fatty acids are present under the same culture conditions. 

Phrase: "However,"

Phrase: "the apoptotic programs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1159821:apoptotic program [Cell Function]
   861   C0376691:Programs [Intellectual Product]
   861   C3484370:Programs [Functional Concept]
   827 E C1709697:Program [Conceptual Entity]
   827 E C2728259:Program [Pharmacologic Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "executed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705848:Executed [Activity]
   966 E C3245498:execute [Functional Concept]

Phrase: "when"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "present under the same culture conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.270: This is supported by the fact that late apoptotic events, such as increases in subdiploid cell population, morphological changes, cytochrome c and AIF detection in the cytosolic fraction, increased Bax and caspase-2 expression, PARP activation, chromatin condensation, and DNA breaks, are clearly monitored when fatty acids are present in the culture medium. 

Phrase: "This"

Phrase: "is"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that late apoptotic events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "such as increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in subdiploid cell population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "morphological changes,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   933   C1260954:Morphologic change [Anatomical Abnormality]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0543482:morphological [Spatial Concept]
   827 E C1705241:Change [Quantitative Concept]
   789 E C0332437:Morphology [Qualitative Concept]
   789 E C0700329:Morphology, NOS [Finding]
   789 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "AIF detection in the cytosolic fraction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "increased Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "caspase-2 expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PARP activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "chromatin condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "DNA breaks,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721104:DNA Breaks [Molecular Function]
   827   C1881704:BREAK [Phenomenon or Process]

Phrase: "are"

Phrase: "clearly"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "when"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "present in the culture medium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.271: Time dependence studies revealed that fatty acids cause an early release of cytochrome c, followed by AIF release and subsequently increased expression of caspase-2 in the cytosol. 

Phrase: "Time dependence studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C0040227:Time Studies [Intellectual Product]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an early release of cytochrome c,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "followed by AIF release"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   833   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   790   C0332283:Followed by [Temporal Concept]
           followed
   783   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0162638:Apoptosis [Cell Function]
   753   C0205263:Inducing [Functional Concept]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2827422:Factor [Conceptual Entity]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "subsequently increased expression of caspase-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.272: Increased caspase-2 levels in the cytosol do not appear to result from its release from mitochondria. 

Phrase: "Increased caspase-2 levels in the cytosol"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result from its release"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1274040:Result [Functional Concept]
   770   C1283071:Release [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   770   C2825142:Result [Finding]

Phrase: "from mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.273: The mechanisms underlying this phenomenon remain to be defined. 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "this phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.274: How do fatty acids considerably accelerate the apoptotic process initiated by serum deprivation? 

Phrase: "How"

Phrase: "do"

Phrase: "fatty acids considerably"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the apoptotic process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162638:Apoptotic Process [Cell Function]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "initiated by serum deprivation?"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0229671:Serum [Body Substance]
   770   C0871712:Deprivation [Qualitative Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]
Processing 00000000.tx.275: This is a complex question in view of the wide variety of effects that these nutrients have on -cell function. 

Phrase: "This"

Phrase: "is"

Phrase: "a complex question in view of the wide variety of effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1522634:Question [Intellectual Product]

Phrase: "that"

Phrase: "these nutrients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678695:Nutrients [Food]
   966 E C2347375:Nutrient [Conceptual Entity]

Phrase: "have"

Phrase: "on -cell function."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.276: Nevertheless, there are several possibilities. 

Phrase: "Nevertheless,"

Phrase: "there"

Phrase: "are"

Phrase: "several possibilities."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C0332149:Possible [Qualitative Concept]
   777   C1705910:Possible [Qualitative Concept]
   777   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.277: The first is through NO production. 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "is through NO production."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0030015:oxide [Inorganic Chemical]
   760   C0033268:production [Occupational Activity]
   760   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.278: Previous reports from Ungers group (4) using isolated islets from the ZDF rat model have suggested that elevated concentrations of fatty acids [mixture oleate/palmitate (2:1) in the presence of 2% BSA, 10% FCS, and 8 mM glucose] promote -cell apoptosis via iNOS induction and NO production. 

Phrase: "Previous reports from Ungers group"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0684224:Reports [Intellectual Product]
   760   C0700287:reports [Health Care Activity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(4"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "isolated islets from the ZDF rat model"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that elevated concentrations of fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "[mixture oleate/palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030233:palmitate [Lipid]
   827   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2% BSA,"

Phrase: "10% FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "8 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "]"

Phrase: "promote -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell apoptosis via iNOS induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C3266896:Apoptosis Induction [Cell Function]
   748   C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "NO production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.279: Consistent with this possibility we found that NO release is increased by both palmitate and oleate. 

Phrase: "Consistent with this possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that NO release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "increased by both palmitate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030233:palmitate [Lipid]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
Processing 00000000.tx.280: However, iNOS was not detected under basal conditions nor apparently induced by fatty acids in INS cells despite a robust induction by cytokines. 

Phrase: "However,"

Phrase: "iNOS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0669372:Inducible NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0132555:NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected under basal conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205112:Basal [Spatial Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "nor"

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "induced by fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   770   C0205263:Induced [Functional Concept]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "in"

Phrase: "INS cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "despite a robust induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.281: These results are in agreement with recent reports in rat and human -cells (32, 39). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "human -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(32,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.282: Thus, we do not favor the view that iNOS induction is implicated in accelerated production of NO caused by fatty acids in INS-1 cells, but do not discount activation of the enzyme by fatty acids or an action of fatty acids on the constitutive isoforms of the enzyme (40). 

Phrase: "Thus,"

Phrase: "we"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that iNOS induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]
   756   C0669372:Inducible NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "implicated in accelerated production of NO"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0033268:production [Occupational Activity]
   748   C0521110:Accelerated [Functional Concept]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "caused by fatty acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   737   C0015127:cause [Functional Concept]
   737 E C0202406:Acid [Laboratory Procedure]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in"

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "discount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555671:discount [Intellectual Product]

Phrase: "activation of the enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0014429:Enzyme Activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "by fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "an action of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "on the constitutive isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.283: The second possibility is ceramide synthesis, in view of the work by Shimabukuro et al. 

Phrase: "The second possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "ceramide synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157399:ceramide synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "in view of the work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "by Shimabukuro et al."
Processing 00000000.tx.284: (7) in ZDF islets. 

Phrase: "(7"

Phrase: ")"

Phrase: "in ZDF islets."
Processing 00000000.tx.285: This possibility is not favored because both palmitate and oleate are proapoptotic in serum-starved INS cells, yet only palmitate serves as a substrate for the de novo synthesis of ceramides (41, 42). 

Phrase: "This possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "favored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "because"

Phrase: "both palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "are"

Phrase: "proapoptotic in serum-starved"

Phrase: "INS cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "yet only palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030233:palmitate [Lipid]
   827   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "serves as a substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: "for the de novo synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   734   C1515568:de novo [Idea or Concept]

Phrase: "of ceramides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramides [Biologically Active Substance,Lipid]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.286: Third, the proapoptotic action of free fatty acids might in part be related to the induction of the immediate-early gene nur-77. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "the proapoptotic action of free fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]

Phrase: "might in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "be"

Phrase: "related to the induction of the immediate-early gene nur-77."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   775   C0206256:Immediate-Early Gene [Gene or Genome]
   754   C0920532:gene induction [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0205253:Immediate [Temporal Concept]
   738   C0205263:Induction [Functional Concept]
   738   C0205548:Immediate [Temporal Concept]
   738   C0439849:Related [Qualitative Concept]
   738   C0445223:Related [Finding]
   738   C0857127:induction [Therapeutic or Preventive Procedure]
   738   C1279919:Early [Temporal Concept]
   704 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.287: Thus, a recent study has described translocation of the nuclear orphan receptor Nur-77 to mitochondria, triggering mitochondrial membrane permeabilization and apoptotic cell death (43). 

Phrase: "Thus,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "described translocation of the nuclear orphan receptor Nur-77"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1518440:Nuclear Translocation [Molecular Function]
   742   C0040715:Translocation [Cell or Molecular Dysfunction]
   742   C2987521:Translocation [Activity]

Phrase: "to mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "mitochondrial membrane permeabilization"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C3158982:mitochondrial membrane permeabilization [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.288: Interestingly, we showed that both palmitate and oleate are very efficient in inducing nur-77 gene expression in isolated islets and INS-1 cells (15). 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "are"

Phrase: "very efficient in inducing nur-77 gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442799:Efficient [Qualitative Concept]

Phrase: "in isolated islets"

Phrase: "and INS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C1414685:INS-1 [Gene or Genome]
   833   C3538717:INS-1 [Gene or Genome]
   770   C0007634:Cells [Cell]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.289: A fourth possibility that we favor is a general toxicity of fatty acids, simply due to the fact that they cannot be oxidized in serum-starved cells because of the mitochondrial membrane potential collapse and mitochondrial function impairment. 

Phrase: "A fourth possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "is"

Phrase: "a general toxicity of fatty acids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]
   720   C0161695:acid poison [Injury or Poisoning]

Phrase: "simply due to the fact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0678226:Due to [Functional Concept]
           due
   760   C3146286:Due [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "cannot"

Phrase: "be"

Phrase: "oxidized in serum-starved cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0229671:Serum [Body Substance]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C3282337:Cells [Cell]
   726   C0030011:oxidize [Molecular Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C2348531:Starve [Activity]

Phrase: "because of the mitochondrial membrane potential collapse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0036974:collapse [Pathologic Function]
   812   C0332521:Collapse [Phenomenon or Process]
   812   C0344329:Collapse [Finding]
   812   C1880118:COLLAPSE [Phenomenon or Process]
   756   C1720920:Membrane Potential, Mitochondrial [Cell Function]

Phrase: "and"

Phrase: "mitochondrial function impairment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.290: Thus, the fate of the excess free fatty acids in this condition is membrane binding as well as lipid esterification processes, leading to the accumulation of reactive long chain acyl-CoAs, acylcarnitines, lysophosphatidic acid, phosphatidic acid, and diacylglycerol (44, 45, 46, 47, 48). 

Phrase: "Thus,"

Phrase: "the fate of the excess free fatty acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1539479:FATE [Gene or Genome]

Phrase: "in this condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "is"

Phrase: "membrane binding"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0025255:Membrane [Tissue]
   861   C0243122:binding [Functional Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "as well as"

Phrase: "lipid esterification processes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "leading to the accumulation of reactive long chain acyl-CoAs,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0001374:Long-Chain Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
           Acyl CoA
   739   C0205166:Long [Qualitative Concept]
   739   C0205332:Reactive [Qualitative Concept]
   739   C0332152:Leading [Temporal Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C1522538:Leading [Functional Concept]
   739   C1524075:Chain [Idea or Concept]
   739   C1706317:Long [Qualitative Concept]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "acylcarnitines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0368608:acylcarnitines [Organic Chemical]

Phrase: "lysophosphatidic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0066772:lysophosphatidic acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "phosphatidic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "diacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(44,"

Phrase: "45,"

Phrase: "46,"

Phrase: "47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.291: In conclusion, serum deprivation is harmful for -cell mitochondrial function, and fatty acids appear to be particularly efficient in accelerating the rate of apoptosis of (INS-1)-cells with already altered mitochondrial function. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "serum deprivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871712:Deprivation [Qualitative Concept]

Phrase: "is"

Phrase: "harmful for -cell mitochondrial function,"

Phrase: "and"

Phrase: "fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "particularly efficient in accelerating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442799:Efficient [Qualitative Concept]

Phrase: "the rate of apoptosis of ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "cells with already"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "mitochondrial function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.292: The precise mechanisms involved in this toxic action of free fatty acids remain to be defined, but are probably multifactorial.  

Phrase: "The precise mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in this toxic action of free fatty acids"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0015688:Free Fatty Acids [Lipid]
   764   C0015684:Fatty Acids [Lipid]
   764   C1256754:toxic action [Hazardous or Poisonous Substance]
   756 E C2698488:Free Fatty Acid [Laboratory Procedure]
   742   C0001128:Acids [Chemical]
   742   C0332296:free [Functional Concept]
   742   C0441472:Action [Functional Concept]
   742   C0600688:toxic [Injury or Poisoning]
   742   C1314939:Involved [Functional Concept]
   742   C1407029:Toxic [Qualitative Concept]
   742   C1880497:Free [Qualitative Concept]
   742   C1996904:Free [Qualitative Concept]
   742   C3266814:Action [Activity]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: ","

Phrase: "but"

Phrase: "are"

Phrase: "probably multifactorial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1837655:Multifactorial [Finding]
Processing 00000000.tx.293: Acknowledgments  We thank Dr. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.294: J. 

Phrase: "J."
Processing 00000000.tx.295: Tejedo and L. 

Phrase: "Tejedo"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.296: Bosc for excellent advise in cytochrome c and Bcl-2 experiments, and Dr. 

Phrase: "Bosc for excellent"

Phrase: "advise in cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   833   C1153524:cytochrome c [Molecular Function]
   833   C1426584:CYTOCHROME C [Gene or Genome]
   770   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "Bcl-2 experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.297: A. 

Phrase: "A."
Processing 00000000.tx.298: Campos for FACS technical assistance.  

Phrase: "Campos for FACS technical assistance."
Processing 00000000.tx.299: Footnotes  This work was supported by grants from Generalitat Valenciana (GV99-139-1-04; to E.R.), Ministerio de Ciencia y Tecnologa (SAF2002-0472; to J.J.), Ministerio de Educacin y Ciencia (PM98-0096; to J.A.R.); 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from Generalitat Valenciana"

Phrase: "(GV99-139-1-04"

Phrase: ";"

Phrase: "to E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Ministerio de Ciencia y Tecnologa"

Phrase: "(SAF2002-0472"

Phrase: ";"

Phrase: "to J.J."

Phrase: ")"

Phrase: ","

Phrase: "Ministerio de Educacin y Ciencia"

Phrase: "(PM98-0096"

Phrase: ";"

Phrase: "to J.A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.300: Comisin de Investigacin de Ciencia y Tecnologa (1FD97-0500 and SAF99-0060) and Fundacin Campollano (to V.C.); 

Phrase: "Comisin de Investigacin de Ciencia y Tecnologa"

Phrase: "(1FD97-0500"

Phrase: "and"

Phrase: "SAF99-0060"

Phrase: ")"

Phrase: "and"

Phrase: "Fundacin Campollano"

Phrase: "("

Phrase: "to V.C."

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.301: the Juvenile Diabetes Research Foundation (McGill and University of Montreal Juvenile Diabetes Research Foundation Center on -Cell Replacement), the Canadian Diabetes Association, and the Juvenile Diabetes Research Foundation (to M.P.); 

Phrase: "the Juvenile Diabetes Research Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "(McGill"

Phrase: "and"

Phrase: "University of Montreal Juvenile Diabetes Research Foundation Center on -Cell Replacement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0035139:Replacement [Therapeutic or Preventive Procedure]
   788   C0559956:Replacement [Functional Concept]
   788   C1555302:Replacement [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "the Canadian Diabetes Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the Juvenile Diabetes Research Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.302: and Secretara de Estado de Universidades e Investigacin (Grant PM99-0142), Fundaci Marat TV3 (Grant 99-1210), and Fundacin Salud 2000 (to B.S.). 

Phrase: "and"

Phrase: "Secretara de Estado de Universidades e Investigacin"

Phrase: "(Grant PM99-0142"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018173:Grant [Quantitative Concept]
   827   C1548284:Grant [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Fundaci Marat TV3"

Phrase: "(Grant 99-1210"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018173:Grant [Quantitative Concept]
   827   C1548284:Grant [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Fundacin Salud 2000"

Phrase: "("

Phrase: "to B.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.303: I.M. is a fellow from Generalitat Valenciana (FPI00-05-79). 

Phrase: "I.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "a fellow from Generalitat Valenciana"

Phrase: "(FPI00-05-79"

Phrase: ")."
Processing 00000000.tx.304: M.C. is a Canadian Institute of Health Research Scientist. 

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "a Canadian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238884:CANADIAN [Finding]

Phrase: "Institute of Health Research Scientist."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0035172:Research Institute [Organization]
   760   C0018684:Health [Idea or Concept]
   760   C0021622:institute [Organization]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C0402112:Scientist [Professional or Occupational Group]
   760   C1272753:Institute [Idea or Concept]
Processing 00000000.tx.305: 1 I.M. and J.J. equally contributed to this work. 

Phrase: "1 I.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "J.J. equally"

Phrase: "contributed to this work."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0043227:Work [Occupational Activity]
   737   C1880177:Contribute [Activity]
Processing 00000000.tx.306: Abbreviations: acyl-CoA, Acyl-coenzyme A; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "acyl-CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Acyl-coenzyme A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001374:Acyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
           acyl coenzyme
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.307: AIF, apoptosis-inducing factor; 

Phrase: "AIF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "apoptosis-inducing factor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.308: FACS, fluorescence-activated cell sorting; 

Phrase: "FACS,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   861   C0007616:Cell Sorting [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0237886:Sorting [Mental Process]
   812   C0700314:sorting [Cell Function]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1879547:Activated [Activity]
   812   C1947906:Sorting [Activity]
   812   C1948049:Cell [Spatial Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "fluorescence-activated cell sorting"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   861   C0007616:Cell Sorting [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0237886:Sorting [Mental Process]
   812   C0700314:sorting [Cell Function]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1879547:Activated [Activity]
   812   C1947906:Sorting [Activity]
   812   C1948049:Cell [Spatial Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.309: FCS, fetal calf serum; 

Phrase: "FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.310: G5, 5 mM glucose; 

Phrase: "G5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422272:G5 [Gene or Genome]

Phrase: "5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.311: GDH, glutamate dehydrogenase; 

Phrase: "GDH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017786:Glutamate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "glutamate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017786:Glutamate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.312: IFN, interferon-; 

Phrase: "IFN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.313: iNOS, inducible nitric oxide synthase; 

Phrase: "iNOS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0669372:Inducible NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0132555:NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase

Phrase: "inducible nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.314: KRB, Krebs-Ringer bicarbonate; 

Phrase: "KRB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   827   C0973231:Bicarbonate [Inorganic Chemical]
   827   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "Krebs-Ringer bicarbonate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   827   C0973231:Bicarbonate [Inorganic Chemical]
   827   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.315: NO, nitric oxide; 

Phrase: "NO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.316: O2-, superoxide radical; 

Phrase: "O2-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "superoxide radical"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0038836:Superoxide Radical [Element, Ion, or Isotope]
           Superoxide
   861   C0302912:Radical [Chemical Viewed Structurally]
   861   C0439807:Radical [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.317: PARP, poly(ADP-ribose) polymerase; 

Phrase: "PARP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "poly(ADP-ribose) polymerase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
  1000   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   923   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001461:ADP Ribose [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035549:Ribose [Carbohydrate]
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0523452:ADP [Laboratory Procedure]
   812   C0747726:POLY [Conceptual Entity]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.318: PMSF, phenylmethylsulfonylfluoride; 

Phrase: "PMSF,"

Phrase: "phenylmethylsulfonylfluoride"

Phrase: ";"
Processing 00000000.tx.319: PVDF, polyvinylidene difluoride; 

Phrase: "PVDF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "polyvinylidene difluoride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.320: ZDF, Zucker diabetic fatty. 

Phrase: "ZDF, Zucker diabetic fatty."
Processing 00000000.tx.321: Received November 12, 2001. 

Phrase: "Received November 12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2001."
Processing 00000000.tx.322: Accepted for publication September 13, 2002.  

Phrase: "Accepted for publication September 13,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2002."
Processing 00000000.tx.323: References Top Abstract Introduction Materials and Methods Results Discussion References  Rabinovitch A 1998 An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References  Rabinovitch"

Phrase: "A 1998"

Phrase: "An update on cytokines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519814:Update [Temporal Concept]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of insulin-dependent diabetes mellitus."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.324: Diabetes Metab Rev 14:129151[CrossRef][Medline] Tejedo J, Bernab JC, Ramrez R, Sobrino F, Bedoya FJ 1999 NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. 

Phrase: "Diabetes Metab Rev 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "129151"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tejedo J,"

Phrase: "Bernab JC,"

Phrase: "Ramrez R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sobrino F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bedoya FJ 1999 NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a cGMP-independent release of cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "which"

Phrase: "precedes"

Phrase: "caspase 3 activation in insulin producing RINm5F cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1159825:Caspase Activation [Molecular Function]
   767   C1326120:activation cells [Cell Function]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.325: FEBS Lett 459:238243[CrossRef][Medline] Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffer M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G 1999 Molecular characterization of mitochondrial apoptosis-inducing factor. 

Phrase: "FEBS Lett 459"

Phrase: ":"

Phrase: "238243"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Susin SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Lorenzo HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Zamzami N,"

Phrase: "Marzo I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Snow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037386:Snow [Natural Phenomenon or Process]
  1000   C1611690:Snow [Substance]

Phrase: "BE"

Phrase: ","

Phrase: "Brothers GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Mangion J,"

Phrase: "Jacotot E,"

Phrase: "Costantini P,"

Phrase: "Loeffer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Larochette N,"

Phrase: "Goodlett DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Aebersold R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Siderovski DP,"

Phrase: "Penninger JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Kroemer G 1999 Molecular characterization of mitochondrial apoptosis-inducing factor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]
Processing 00000000.tx.326: Nature 397:441446[CrossRef][Medline] Shimabukuro M, Ohneda M, Lee Y, Unger RH 1997 Role of nitric oxide in obesity-induced -cell disease. 

Phrase: "Nature 397"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "441446"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohneda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee Y,"

Phrase: "Unger RH 1997 Role of nitric oxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in obesity-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.327: J Clin Invest 100:290295[Abstract/Free FullText] Shimabukuro M, Zhou Y-T, Levi M, Unger RH 1998 Fatty acid-induced  cell apoptosis: a link between obesity and diabetes. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "100"

Phrase: ":"

Phrase: "290295"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou Y-T,"

Phrase: "Levi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Unger RH 1998 Fatty acid-induced  cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0162638:Apoptosis [Cell Function]
   721 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "a link between obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.328: Proc Natl Acad Sci USA 95:24982502[Abstract/Free FullText] Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH 1998 Protection against lipoapoptosis of -cells through leptin-dependent maintenance of Bcl-2 expression. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "24982502"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wang"

Phrase: "MY,"

Phrase: "Zhou YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Newgard CB,"

Phrase: "Unger RH 1998 Protection against lipoapoptosis of -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0524828:Cell Protection [Physiologic Function]
   744   C1545588:Protection [Finding]

Phrase: "through leptin-dependent maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024501:Maintenance [Activity]

Phrase: "of Bcl-2 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0376515:Bcl-2 [Gene or Genome]
Processing 00000000.tx.329: Proc Natl Acad Sci USA 95:95589561[Abstract/Free FullText] Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in -cells of obese prediabetic fa/fa rats. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "95589561"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Higa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Wang"

Phrase: "MY,"

Phrase: "Newgard CB,"

Phrase: "Unger RH 1998 Lipoapoptosis in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "of obese prediabetic fa/fa rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
Processing 00000000.tx.330: Role of serine palmitoyltransferase overexpression. 

Phrase: "Role of serine palmitoyltransferase overexpression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.331: J Biol Chem 273:3248732490[Abstract/Free FullText] Brun T, Assimacopoulos-Jeannet F, Corkey B, Prentki M 1997 Long chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic -cell line INS-1. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3248732490"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brun T,"

Phrase: "Assimacopoulos-Jeannet F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Corkey B,"

Phrase: "Prentki M 1997 Long chain fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   844   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   818   C0015684:Fatty Acids [Lipid]
   795   C0001128:Acids [Chemical]
   795   C0205166:Long [Qualitative Concept]
   795   C0337112:Chain [Manufactured Object]
   795   C1524075:Chain [Idea or Concept]
   795   C1706317:Long [Qualitative Concept]
   762 E C0202406:Acid [Laboratory Procedure]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "acetyl-CoA carboxylase gene expression in the pancreatic -cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017262:Gene Expression [Genetic Function]
   757   C1861886:CELL Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.332: Diabetes 46:393400[Abstract] Segall L, Lameloise N, Assimacopoulos-Jeannet F, Roche E, Corkey P. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "393400"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Segall L,"

Phrase: "Lameloise N,"

Phrase: "Assimacopoulos-Jeannet F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Roche E,"

Phrase: "Corkey P."
Processing 00000000.tx.333: Thumelin S, Corkey BE, Prentki M 1999 Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. 

Phrase: "Thumelin S,"

Phrase: "Corkey"

Phrase: "BE"

Phrase: ","

Phrase: "Prentki M 1999 Lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023779:Lipid [Lipid]

Phrase: "rather than"

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "implicated in altered insulin secretion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0392747:Altered [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "caused by oleate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0133788:oleate [Lipid]
   790   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "in"

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.334: Am J Physiol 277: E521E528 Zhou Y-T, Shimabukuro M, Koyama K, Lee Y, Wang M-Y, Trieu F, Newgard CB, Unger RH 1997 Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. 

Phrase: "Am"

Phrase: "J Physiol 277"

Phrase: ":"

Phrase: "E521E528 Zhou Y-T,"

Phrase: "Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Koyama K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lee Y,"

Phrase: "Wang"

Phrase: "M-"

Phrase: "Y,"

Phrase: "Trieu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Newgard CB,"

Phrase: "Unger RH 1997 Induction by leptin of uncoupling protein-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205263:Induction [Functional Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "enzymes of fatty acid oxidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.335: Proc Natl Acad Sci USA 94:63866390[Abstract/Free FullText] Zhou Y-T, Shimabukuro M, Wang M-Y, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH 1998 Role of peroxisome proliferator-activated receptor in disease of pancreatic  cells. 

Phrase: "Proc Natl Acad Sci USA 94"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "63866390"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhou Y-T,"

Phrase: "Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wang"

Phrase: "M-"

Phrase: "Y,"

Phrase: "Lee Y,"

Phrase: "Higa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Milburn JL,"

Phrase: "Newgard CB,"

Phrase: "Unger RH 1998 Role of peroxisome proliferator-activated receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "of pancreatic  cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.336: Proc Natl Acad Sci USA 95:88988903[Abstract/Free FullText] Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F 2001 Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "88988903"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lameloise N,"

Phrase: "Muzzin P,"

Phrase: "Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Assimacopoulos-Jeannet F 2001 Uncoupling protein 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   845   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   845   C2945724:f-protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a possible link between fatty acid excess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "impaired glucose-induced insulin secretion?"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.337: Diabetes 50:803809[Abstract/Free FullText] Prentki M, Roduit R, Lameloise N, Corkey BE, Assimacopoulos-Jeannet F 2000 Glucotoxicity, lipotoxicity and pancreatic -cell failure: a role for malonyl-CoA, PPAR and altered lipid partitioning? 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "803809"

Phrase: "[Abstract/Free FullText"

Phrase: "] Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roduit R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lameloise N,"

Phrase: "Corkey"

Phrase: "BE"

Phrase: ","

Phrase: "Assimacopoulos-Jeannet F 2000 Glucotoxicity,"

Phrase: "lipotoxicity"

Phrase: "and"

Phrase: "pancreatic -cell failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: ":"

Phrase: "a role for malonyl-CoA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "PPAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166418:PPAR [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PPAR [Gene or Genome]
  1000   C2984537:PPAR [Gene or Genome]

Phrase: "and"

Phrase: "altered lipid partitioning?"
Processing 00000000.tx.338: Can J Diabetes Care 25:3646 Roucou X, Antonsson B, Martinou JC 2001 Involvement of mitochondria in apoptosis. 

Phrase: "Can"

Phrase: "J Diabetes Care 25"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C1947933:Care [Activity]

Phrase: ":"

Phrase: "3646 Roucou X,"

Phrase: "Antonsson B,"

Phrase: "Martinou JC 2001 Involvement of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.339: Cardiol Clin 19:4555[Medline] Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M 1999 Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic -cell line INS-1. 

Phrase: "Cardiol Clin 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "4555"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roche E,"

Phrase: "Buteau J,"

Phrase: "Aniento I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Reig JA,"

Phrase: "Soria B,"

Phrase: "Prentki M 1999 Palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the immediate-early response genes c-fos"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C1415884:IMMEDIATE-EARLY RESPONSE GENE [Gene or Genome]
   700   C0206256:Genes, Immediate-Early [Gene or Genome]

Phrase: "and"

Phrase: "nur-77 in the pancreatic -cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.340: Diabetes 48:20072014[Abstract] Jordan J, Galindo MF, Calvo S, Gonzalez-Garcia C, Cea V 2000 Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "20072014"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jordan J,"

Phrase: "Galindo MF,"

Phrase: "Calvo S,"

Phrase: "Gonzalez-Garcia C,"

Phrase: "Cea V 2000 Veratridine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0042525:Veratridine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptotic death in bovine chromaffin cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   803   C0162638:apoptotic cell death [Cell Function]
   783   C0007587:cells death [Cell Function]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "through superoxide production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.341: Br J Pharmacol 130:14961504[Abstract/Free FullText] Bern E, Bergmeyer HU 1963 Determination of glutamate dehydrogenase enzymatic activity. 

Phrase: "Br J Pharmacol 130"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "14961504"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bern E,"

Phrase: "Bergmeyer HU 1963 Determination of glutamate dehydrogenase enzymatic activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.342: In: Bergmeyer HU, ed. 

Phrase: "In"

Phrase: ":"

Phrase: "Bergmeyer HU,"

Phrase: "ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.343: Methods of enzymatic analysis. 

Phrase: "Methods of enzymatic analysis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   802   C2707190:Analysis method [Laboratory Procedure]
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.344: New York: Academic Press; 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Academic Press"

Phrase: ";"
Processing 00000000.tx.345: 384388 Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR 1982 Analysis of nitrate, nitrite and (15N)nitrate in biological fluids. 

Phrase: "384388 Green LC,"

Phrase: "Wagner DA,"

Phrase: "Glogowski J,"

Phrase: "Skipper PL,"

Phrase: "Wishnok JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Tannenbaum SR 1982 Analysis of nitrate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "nitrite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028137:Nitrite [Chemical Viewed Structurally]
  1000   C1384115:Nitrite [Inorganic Chemical]

Phrase: "and ("

Phrase: "15N"

Phrase: ")"

Phrase: "nitrate in biological fluids."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0028125:Nitrate [Chemical Viewed Structurally]
   770   C0699857:Nitrate [Inorganic Chemical]
Processing 00000000.tx.346: Anal Biochem 126:131138[Medline] Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y 1999 Hyperglycemia causes oxidative stress in pancreatic -cells of GK rats, a model of type 2 diabetes. 

Phrase: "Anal Biochem 126"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "131138"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ihara Y,"

Phrase: "Toyokuni S,"

Phrase: "Uchida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Odaka H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka T,"

Phrase: "Ikeda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hiai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Seino Y,"

Phrase: "Yamada Y 1999 Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "oxidative stress in pancreatic -cells of GK rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   744   C0038435:Stress [Finding]
   744   C0311404:Oxidative [Functional Concept]

Phrase: "a model of type 2 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.347: Diabetes 48:927932[Abstract] Tajiri Y, Moller C, Grill V 1997 Long term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "927932"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tajiri Y,"

Phrase: "Moller C,"

Phrase: "Grill V 1997 Long term effects of aminoguanidine"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0023983:Long-Term Effects [Phenomenon or Process]
   770   C0443252:Long-term [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C1280500:effects [Qualitative Concept]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]

Phrase: ":"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the formation of advanced glycosylation end products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "B cell function."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007613:Cell Function [Cell Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0004561:B-cell [Cell]
Processing 00000000.tx.348: Endocrinology 138:273280[Abstract/Free FullText] Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N 1996 Reducing sugars trigger oxidative modification and apoptosis in pancreatic -cells by provoking oxidative stress through the glycation reaction. 

Phrase: "Endocrinology 138"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "273280"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kaneto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Fujii J,"

Phrase: "Myint T,"

Phrase: "Miyazawa N,"

Phrase: "Islam KN,"

Phrase: "Kawasaki Y,"

Phrase: "Suzuki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nakamura M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tatsumi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yamasaki Y,"

Phrase: "Taniguchi N 1996 Reducing sugars"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0242209:Sugars [Carbohydrate,Pharmacologic Substance]
   804   C0392756:Reducing [Qualitative Concept]
   771 E C0007004:Sugar [Carbohydrate]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "oxidative modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "apoptosis in pancreatic -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "by provoking oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "through the glycation reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.349: Biochem J 320:855863[Medline] Yuste VJ, Snchez-Lpez I, Sole C, Encinas M, Bayascas JR, Boix J, Comella JX 2002 The prevention of the staurosporine-induced apoptosis by Bcl-xL, but not by Bcl-2 or caspase inhibitors, allows the extensive differentiation of human neuroblastoma cells. 

Phrase: "Biochem J 320"

Phrase: ":"

Phrase: "855863"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yuste VJ,"

Phrase: "Snchez-Lpez I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sole C,"

Phrase: "Encinas M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bayascas JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Boix J,"

Phrase: "Comella JX 2002"

Phrase: "The prevention of the staurosporine-induced apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]

Phrase: "by Bcl-xL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "but"

Phrase: "not by Bcl-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0376515:Bcl-2 [Gene or Genome]
   770   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "caspase inhibitors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the extensive differentiation of human neuroblastoma cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0007589:cells differentiation [Cell Function]
           Differentiation
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.350: J Neurochem 80:126139[CrossRef][Medline] Feng G, Kaplowitz N 2002 Mechanism of staurosporine-induced apoptosis in murine hepatocytes. 

Phrase: "J Neurochem 80"

Phrase: ":"

Phrase: "126139"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Feng G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kaplowitz N 2002 Mechanism of staurosporine-induced apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "in murine hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.351: Am J Physiol 282:G825G834 Hengartner MO 2000 The biochemistry of apoptosis. 

Phrase: "Am"

Phrase: "J Physiol 282"

Phrase: ":"

Phrase: "G825G834 Hengartner MO 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538743:MO [Idea or Concept]

Phrase: "The biochemistry of apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.352: Nature 407:770776[CrossRef][Medline] Green DR 2000 Apoptotic pathways: paper wraps stone blunts scissors. 

Phrase: "Nature 407"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "770776"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Green DR 2000 Apoptotic pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   787   C0162638:Apoptosis Pathway [Cell Function]

Phrase: ":"

Phrase: "paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "wraps"

Phrase: "stone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006736:Stone [Body Substance]
   928 E C0443312:Stoney [Qualitative Concept]

Phrase: "blunts"

Phrase: "scissors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175735:Scissors [Medical Device]
Processing 00000000.tx.353: Cell 102:14[Medline] Ferri KF, Kroemer G 2001 Mitochondria-the suicide organelles. 

Phrase: "Cell 102"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "14"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ferri KF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427198:KF [Gene or Genome]

Phrase: "Kroemer G 2001 Mitochondria-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0026237:Mitochondria [Cell Component]

Phrase: "the suicide organelles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]
Processing 00000000.tx.354: BioEssays 23:111115[CrossRef][Medline] Kroemer G, Dallaporta B, Resche-Rigon M 1998 The mitochondrial death/life regulator in apoptosis and necrosis. 

Phrase: "BioEssays 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "111115"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kroemer G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Dallaporta B,"

Phrase: "Resche-Rigon M 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "The mitochondrial death/life regulator in apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1564881:Apoptosis Regulator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0182953:REGULATOR [Medical Device]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]
Processing 00000000.tx.355: Annu Rev Physiol 60:619642[CrossRef][Medline] Bernardi P, Scorrano L, Colonna R, Petronili V, Di Lisa F 1999 Mitochondria and cell death. 

Phrase: "Annu Rev Physiol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "619642"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bernardi P,"

Phrase: "Scorrano L,"

Phrase: "Colonna R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Petronili V,"

Phrase: "Di Lisa F 1999 Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.356: Mechanistic aspects and methodological issues. 

Phrase: "Mechanistic aspects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]

Phrase: "and"

Phrase: "methodological issues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.357: Eur J Biochem 264:687701[Abstract/Free FullText] Daugas E, Nochy D, Ravagnan L, Leffer M, Susin SA, Zamzami N, Kroemer G 2000 Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. 

Phrase: "Eur J Biochem 264"

Phrase: ":"

Phrase: "687701"

Phrase: "[Abstract/Free FullText"

Phrase: "] Daugas E,"

Phrase: "Nochy D,"

Phrase: "Ravagnan L,"

Phrase: "Leffer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Susin SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Zamzami N,"

Phrase: "Kroemer G 2000 Apoptosis-inducing factor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   799   C0162638:Apoptosis [Cell Function]
   799   C0205263:Inducing [Functional Concept]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   727 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(AIF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ")"

Phrase: ":"

Phrase: "a ubiquitous mitochondrial oxidoreductase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030016:Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1537381:oxidoreductase [Gene or Genome]

Phrase: "involved in apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1314939:Involved [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.358: FEBS Lett 476:118123[CrossRef][Medline] Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, Prevost MC, Alzari PM, Kroemer G 1999 Mitochondrial release of caspase-2 and -9 during the apoptotic process. 

Phrase: "FEBS Lett 476"

Phrase: ":"

Phrase: "118123"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Susin SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Lorenzo HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Zamzami N,"

Phrase: "Marzo I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brenner C,"

Phrase: "Larochette N,"

Phrase: "Prevost MC,"

Phrase: "Alzari PM, Kroemer G 1999 Mitochondrial release of caspase-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "9 during the apoptotic process."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0162638:Apoptotic Process [Cell Function]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.359: J Exp Med 189:381394[Abstract/Free FullText] Huo J, Luo R-H, Metz SA, Li G 2002 Activation of caspase-2 mediates the apoptosis induced by GTP-depletion in insulin-secreting (HIT-T15) cells. 

Phrase: "J Exp Med 189"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "381394"

Phrase: "[Abstract/Free FullText"

Phrase: "] Huo J,"

Phrase: "Luo R-H,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0205090:R- [Spatial Concept]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Metz SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Li G 2002 Activation of caspase-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1159825:Caspase Activation [Molecular Function]
   748   C1879547:Activation [Activity]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by GTP-depletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205263:Induced [Functional Concept]
   770   C0333668:Depletion [Functional Concept]

Phrase: "in insulin-secreting"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1327616:Secreting [Cell Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(HIT-T15"

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.360: Endocrinology 143:16951704[Abstract/Free FullText] Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patan G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P 2002 Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets. 

Phrase: "Endocrinology 143"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "16951704"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marselli L,"

Phrase: "Del Guerra S,"

Phrase: "Masini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Santangelo C,"

Phrase: "Patan G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Boggi U,"

Phrase: "Piro S,"

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bergamini E,"

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Di Mario U,"

Phrase: "Del Prato S,"

Phrase: "Marchetti P 2002 Prolonged exposure to free fatty acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0332157:Exposure to [Clinical Attribute]
           Exposure
   742   C0274281:Exposure, NOS [Injury or Poisoning]
   742   C0439590:Prolonged [Temporal Concept]

Phrase: "has"

Phrase: "cytostatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010858:cytostatic [Pharmacologic Substance]

Phrase: "and"

Phrase: "pro-apoptotic effects on human pancreatic islets."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.361: Evidence that -cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that -cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "caspase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "partially dependent on ceramide pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.362: Diabetes 51:14371442[Abstract/Free FullText] Castrillo A, Bodelon OG, Bosc L 2000 Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in INS-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "14371442"

Phrase: "[Abstract/Free FullText"

Phrase: "] Castrillo A,"

Phrase: "Bodelon OG,"

Phrase: "Bosc L 2000 Inhibitory effect of IGF-I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on type 2 nitric oxide synthase expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "protection against activation-dependent apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: ":"

Phrase: "involvement of phosphatidylinositol 3-kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.363: Diabetes 49:209217[Abstract] Tiedge M, Lortz S, Drinkgern J, Lenzen S 1997 Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "209217"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tiedge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lortz S,"

Phrase: "Drinkgern J,"

Phrase: "Lenzen S 1997 Relation between antioxidant enzyme gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0080103:Relation [Family Group]
   742   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "antioxidative defense status of insulin-producing cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.364: Diabetes 46:17331742[Abstract] Adams JM, Cory S 1998 The Bcl-2 protein family: arbiters of cell survival. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "17331742"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Adams JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Cory S 1998"

Phrase: "The Bcl-2 protein family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   756   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0241888:Familial [Functional Concept]

Phrase: ":"

Phrase: "arbiters of cell survival."
Processing 00000000.tx.365: Science 281:13221326[Abstract/Free FullText] Aravind L, Dixit VM, Koonin EV 1999 The domains of death: evolution of the apoptosis machinery. 

Phrase: "Science 281"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "13221326"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aravind L,"

Phrase: "Dixit VM,"

Phrase: "Koonin EV 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014522:EV [Neoplastic Process]
   827   C0560135:eV [Quantitative Concept]

Phrase: "The domains of death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1511738:Death Domain [Amino Acid Sequence]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: ":"

Phrase: "evolution of the apoptosis machinery."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015219:Evolution [Genetic Function]
Processing 00000000.tx.366: Trends Biochem Sci 24:4753[CrossRef][Medline] Wolf BB, Green DR 1999 Suicidal tendencies: apoptotic cell death by caspase family proteinases. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem Sci 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "4753"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolf BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Green DR 1999 Suicidal tendencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   823   C0235196:SUICIDAL TENDENCY [Finding]

Phrase: ":"

Phrase: "apoptotic cell death by caspase family proteinases."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0162638:apoptotic cell death [Cell Function]
   778   C0007587:Cell Death [Cell Function]
   774   C0425043:death family [Finding]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.367: J Biol Chem 274:2004920052[Free FullText] Kidd VJ 1998 Proteolytic activities that mediate apoptosis. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2004920052"

Phrase: "[Free FullText"

Phrase: "] Kidd VJ 1998 Proteolytic activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0441655:Activities [Activity]
   804   C0597304:Proteolytic [Molecular Function]
   804   C1947941:proteolytic [Enzyme]
   771 E C0205177:Activity [Functional Concept]
   771 E C0439167:% activity [Quantitative Concept]
   771 E C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.368: Annu Rev Physiol 60:533573[CrossRef][Medline] Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG 2001 Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. 

Phrase: "Annu Rev Physiol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "533573"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cnop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hannaert JC,"

Phrase: "Hoorens A,"

Phrase: "Eizirik DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Pipeleers DG 2001 Inverse relationship between cytotoxicity of free fatty acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0439849:Relationship [Qualitative Concept]
   738   C1705630:Relationship [Idea or Concept]
   738   C1706279:Relationship [Idea or Concept]
   738   C3540605:Relationship [Intellectual Product]

Phrase: "in pancreatic islet cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   983   C0734999:Pancreatic islet cell [Cell]
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cellular triglyceride accumulation."
Processing 00000000.tx.369: Diabetes 50:17711777[Abstract/Free FullText] Lajoix AD, Reggio H, Chardes T, Peraldi-Roux S, Tribillac F, Roye Broca C, Manteghetti M, Ribes G, Wollheim CB, Gross R 2001 A neuronal isoform of nitric oxide synthase expressed in pancreatic -cells controls insulin secretion. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "17711777"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lajoix AD,"

Phrase: "Reggio H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chardes T,"

Phrase: "Peraldi-Roux S,"

Phrase: "Tribillac F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Roye Broca C,"

Phrase: "Manteghetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ribes G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Wollheim CB,"

Phrase: "Gross R 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205090:R- [Spatial Concept]
   827   C0439806:Gross [Qualitative Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "A neuronal isoform of nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "expressed in pancreatic -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.370: Diabetes 50:13111323[Abstract/Free FullText] Kolesnick RN, Krnke M 1998 Regulation of ceramide production and apoptosis. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "13111323"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kolesnick RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Krnke M 1998 Regulation of ceramide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.371: Annu Rev Physiol 60:643665[CrossRef][Medline] Mathias S, Pea LA, Kolesnick RN 1998 Signal transduction of stress via ceramide. 

Phrase: "Annu Rev Physiol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "643665"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mathias S,"

Phrase: "Pea LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Kolesnick RN 1998 Signal transduction of stress"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0037083:Signal Transduction [Cell Function]
   748   C1160185:transduction [Organism Function]
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "via ceramide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]
Processing 00000000.tx.372: Biochem J 335:465480[Medline] Li H, Kolluri SK, Gu J, Daxson MJ, Cao X, Hobbs PD, Lin B, Chen G-Q, Lu J-S, Lin F, Xie Z, Fontana JA, Reed JC, Zhang X 2000 Cytochrome c release and apoptosis induced by mitochondrial targeting of orphan receptor TR3-nur77-NGFI-B. 

Phrase: "Biochem J 335"

Phrase: ":"

Phrase: "465480"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kolluri SK,"

Phrase: "Gu J,"

Phrase: "Daxson MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Cao X,"

Phrase: "Hobbs PD,"

Phrase: "Lin B,"

Phrase: "Chen G-Q,"

Phrase: "Lu J-S,"

Phrase: "Lin F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Xie Z,"

Phrase: "Fontana JA,"

Phrase: "Reed JC,"

Phrase: "Zhang X 2000 Cytochrome c release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030685:Release [Health Care Activity]
   799   C0391871:Release [Functional Concept]
   799   C0439180:% release [Quantitative Concept]
   799   C0680255:release [Health Care Activity]
   799   C1283071:Release [Functional Concept]
   799   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by mitochondrial targeting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0205263:Induced [Functional Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1521840:Targeting [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "of orphan receptor TR3-nur77-NGFI-B."
Processing 00000000.tx.373: Science 289:11591164[Abstract/Free FullText] Prentki M, Corkey BE 1996 Are the -cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? 

Phrase: "Science 289"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "11591164"

Phrase: "[Abstract/Free FullText"

Phrase: "] Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Corkey"

Phrase: "BE"

Phrase: "1996"

Phrase: "Are"

Phrase: "the -cell signaling molecules malonyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cytosolic long-chain acyl-CoA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   937   C0001374:Long-Chain Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
           Acyl CoA

Phrase: "implicated in multiple tissue defects of obesity"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0028754:Obesity [Disease or Syndrome]
   748   C0040300:Tissue [Tissue]
   748   C0243067:defects [Functional Concept]
   748   C0439064:Multiple [Quantitative Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C1963185:Obesity [Finding]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "NIDDM?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011860:NIDDM [Disease or Syndrome]
  1000   C3273872:NIDDM [Gene or Genome]
Processing 00000000.tx.374: Diabetes 45:273283[Abstract] Unger RH 1995 Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "273283"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Unger RH 1995 Lipotoxicity in the pathogenesis of obesity-dependent NIDDM."
Processing 00000000.tx.375: Genetic and clinical implications. 

Phrase: "Genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "clinical implications."
Processing 00000000.tx.376: Diabetes 44:863870[Abstract] Mutomba MC, Yuan H, Konyavko M, Adachi S, Yokoyama CB, Esser V, McGarry D, Babior BM, Gottlieb RA 2000 Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "863870"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mutomba MC,"

Phrase: "Yuan H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Konyavko M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Adachi S,"

Phrase: "Yokoyama CB,"

Phrase: "Esser V,"

Phrase: "McGarry D,"

Phrase: "Babior BM,"

Phrase: "Gottlieb RA 2000 Regulation of the activity of caspases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   796   C1752742:regulation of caspase activity [Molecular Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "by L-carnitine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007258:L-Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Carnitine
  1000   C0087163:L-Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
           Carnitine
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "palmitoylcarnitine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030242:Palmitoylcarnitine [Amino Acid, Peptide, or Protein,Vitamin]
Processing 00000000.tx.377: FEBS Lett 478:1925[CrossRef][Medline] Paumen MB, Ishida Y, Muramatsu M, Yamamoto M, Honjo T 1997 Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. 

Phrase: "FEBS Lett 478"

Phrase: ":"

Phrase: "1925"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paumen MB,"

Phrase: "Ishida Y,"

Phrase: "Muramatsu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamamoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Honjo T 1997 Inhibition of carnitine palmitoyltransferase I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "sphingolipid synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157397:sphingolipid synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "palmitate-induced apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.378: J Biol Chem 272:33243329[Abstract/Free FullText] Furuno T, Kanno T, Arita K, Asami M, Utsumi T, Doi Y, Inoue M, Utsumi K 2001 Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "33243329"

Phrase: "[Abstract/Free FullText"

Phrase: "] Furuno T,"

Phrase: "Kanno T,"

Phrase: "Arita K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Asami M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Utsumi T,"

Phrase: "Doi Y,"

Phrase: "Inoue M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Utsumi K 2001 Roles of long chain fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0035820:Roles [Social Behavior]
   708 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "carnitine in mitochondrial membrane permeability transition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   716   C3158981:mitochondrial membrane permeability transition [Cell Function]
Processing 00000000.tx.379: Biochem Pharmacol 62:10371046[CrossRef][Medline]

Phrase: "Biochem Pharmacol 62"

Phrase: ":"

Phrase: "10371046"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

